A krónikus betegség kohorszának alkotmányának károsodott mobilitásának értékelése (EVALMOB)
Chronic illness is a public health issue and mobility loss is frequent in this population. Among its' multiple physical and psychological consequences, increased mortality and cardiovascular morbidity seem the main concern. Therefore, the exploration of locomotor deficiencies, physical capacities and metabolism of patients with chronic illnesses constitutes a major challenge both for the treatment of causal pathologies, as well as for evaluating the impact of therapeutic interventions, the benefit of which will be an improvement in physical capacities and ultimately mobility. In view of the hypothesis of an increase in the prevalence of mobility disorders in this population, this approach is part of a logic of screening and improving the effectiveness of the care of these patients with a multidisciplinary evaluation of individual risks. The EVALMOB protocol was designed in order to try to determine a standard profile of "dysmobility" in patients with chronic illness
A tanulmány áttekintése
Állapot
Körülmények
Részletes leírás
We propose to constitute a prospective cohort of subjects carrying chronic disease. The objective is to explore all the different components of mobility (balance, muscle force, body composition, walking ability, metabolism, etc.), to assess their impact on the functional capacity of individuals and to identify their potential interactions. Processing this data could ultimately allow the development of a model to determine a composite standard profile of "dysmobility" in patients with chronic disease.
In the present protocol, parameters will be measured on five occasions (at inclusion, at 6 months from the inclusion day, at 1,2 and 5 year(s) from the inclusion day). All tests will be performed on the same day. New assessments will be done on the same principle as the initial evaluation.
Statistical analyses will be carried out using Stata software (version 13, StataCorp, College Station, USA). Data will be described by frequencies and percentages for categorical variables and by means and standard deviation (or median and interquartile range if data are not normally distributed) for continuous variables. The normality of continuous data will be assessed graphically and using the Shapiro-Wilk test. The main analysis will consist in determining patient profiles regarding their mobility. Clustering-type approaches (supervised or not) will be proposed: k-means, vector machine support, machine learning, factor analysis. For example, factor analyses on mixed data will allow the main components of mobility to be characterized. They can be followed by an ascending hierarchical classification in order to determine homogeneous groups of patients.
These groups will be described and compared on the main criteria evaluated using standard statistical tests: chi2 test (or Fisher's exact test if applicable) for the categorical criteria and using an analysis of variance (or Kruskal-Wallis if data are not normally distributed) for continuous criteria. The main analysis will be broken down more specifically for each of the pathologies considered. In addition, the sensitivity to change will be assessed in each pathology and for each assessment criterion. The search for factors related to the evolution of the different criteria will be carried out using usual tests and mixed multivariate models (logistics for categorical / linear criteria for continuous criteria) considering the subject as a random effect, and adjusting on the time criteria (inclusion / follow-up) and the criteria highlighted in the univariate analyses and in light of the elements reported in the literature. A sensitivity analysis will be proposed in order to study the statistical nature of the missing data and to propose, if necessary, the most suitable method of imputing the data: multiple imputation, maximum bias or LOCF in the case of longitudinal data.
Tanulmány típusa
Beiratkozás (Becsült)
Fázis
- Nem alkalmazható
Kapcsolatok és helyek
Tanulmányi kapcsolat
- Név: Lise Laclautre
- Telefonszám: 334.73.754.963
- E-mail: promo_interne_drci@chu-clermontferrand.fr
Tanulmányi helyek
-
-
-
Clermont-Ferrand, Franciaország, 63003
- Toborzás
- Chu Clermont Ferrand
-
Kutatásvezető:
- Frédéric Costes
-
Kapcsolatba lépni:
- Lise Laclautre
- E-mail: promo_interne_drci@chu-clermontferrand.fr
-
-
Részvételi kritériumok
Jogosultsági kritériumok
Tanulmányozható életkorok
Egészséges önkénteseket fogad
Tanulmányozható nemek
Leírás
Inclusion Criteria:
- Man or woman aged 18 to 90.
- Patients with chronic pathology contributing to impaired mobility.
- Volunteers who have given their written consent.
- Affiliated to French health care system (for France)
Exclusion Criteria:
- Patients suffering from progressive psychiatric pathologies (active psychosis, hallucinations, etc.) or the presence of another serious unstabilized pathology (decompensated heart failure, progressive terminal cancer, etc.).
- People with poorly controlled or unstable cardiovascular disease.
- Major osteoarticular or neurological problems completely preventing the proper performance of the various tests.
- Non-autonomous patient
- Persons under guardianship, curatorship, deprived of liberty or safeguarding justice.
- People excluded from another study.
- Pregnant or lactating women.
Tanulási terv
Hogyan készül a tanulmány?
Tervezési részletek
- Elsődleges cél: Diagnosztikai
- Kiosztás: N/A
- Beavatkozó modell: Egyetlen csoportos hozzárendelés
- Maszkolás: Nincs (Open Label)
Fegyverek és beavatkozások
Résztvevő csoport / kar |
Beavatkozás / kezelés |
|---|---|
|
Kísérleti: Cohort 1
Participants will be involved in a long-term evaluation program combining, body composition measures, physical tests as well as self-administered questionnaires. Participants will be followed for 5 years with evaluations taking place at inclusion, 6 months, at 1, 2 and 5 years |
Firstly, volunteers will be invited to complete online questionnaires on a secure platform. The mobility assessment will be carried out initially (t1) and up to a maximum of 4 times (t1 to t4) as part of a day hospitalization. Questionnaires will be diverse (SF36, KOOS, HOOS, BROCKER, MNA, TAMPA, etc.) in order to assess several aspects that compose mobility. Physical evaluations will include various validated tests (isokinetic strength measure, TUG, 6MWT, Berg Balance Scale, etc.) |
Mit mér a tanulmány?
Elsődleges eredményintézkedések
Eredménymérő |
Intézkedés leírása |
Időkeret |
|---|---|---|
|
dismobility score calculated from the results reported in secondary outcomes
Időkeret: Day 0
|
The main objective being to determine patient profiles with regard to "dysmobility", all the criteria detailed as secondary outcomes will be considered for the definition of the profiles |
Day 0
|
|
dismobility score calculated from the results reported in secondary outcomes
Időkeret: Month 6
|
The main objective being to determine patient profiles with regard to "dysmobility", all the criteria detailed as secondary outcomes will be considered for the definition of the profiles |
Month 6
|
|
dismobility score calculated from the results reported in secondary outcomes
Időkeret: Year 1
|
The main objective being to determine patient profiles with regard to "dysmobility", all the criteria detailed as secondary outcomes will be considered for the definition of the profiles |
Year 1
|
|
dismobility score calculated from the results reported in secondary outcomes
Időkeret: Year 2
|
The main objective being to determine patient profiles with regard to "dysmobility", all the criteria detailed as secondary outcomes will be considered for the definition of the profiles |
Year 2
|
|
dismobility score calculated from the results reported in secondary outcomes
Időkeret: Year 5
|
The main objective being to determine patient profiles with regard to "dysmobility", all the criteria detailed as secondary outcomes will be considered for the definition of the profiles |
Year 5
|
Másodlagos eredményintézkedések
Eredménymérő |
Intézkedés leírása |
Időkeret |
|---|---|---|
|
The main objective being to determine patient profiles with regard to "dysmobility", all the criteria detailed as secondary outcomes will be considered for the definition of the profiles
Időkeret: Day 0
|
Demographics information will be obtained using a single questionnaire including questions on age, gender, qualification, personal work status, ethnicity, life and occupational events. |
Day 0
|
|
Weight (Kg).
Időkeret: Day 0
|
Weight will be measured with the medical body weight scale SECA® and according to the ISAK recommendations. |
Day 0
|
|
Weight (Kg).
Időkeret: Month 6
|
Weight will be measured with the medical body weight scale SECA® and according to the ISAK recommendations. |
Month 6
|
|
Weight (Kg).
Időkeret: Year 1
|
Weight will be measured with the medical body weight scale SECA® and according to the ISAK recommendations. |
Year 1
|
|
Weight (Kg).
Időkeret: Year 2
|
Weight will be measured with the medical body weight scale SECA® and according to the ISAK recommendations. |
Year 2
|
|
Weight (Kg).
Időkeret: Year 5
|
Weight will be measured with the medical body weight scale SECA® and according to the ISAK recommendations. |
Year 5
|
|
Height (cm).
Időkeret: Day 0
|
Height will be measured with a wall mounted tape measure and according to the ISAK recommendations |
Day 0
|
|
Height (cm).
Időkeret: Month 6
|
Height will be measured with a wall mounted tape measure and according to the ISAK recommendations |
Month 6
|
|
Height (cm).
Időkeret: Year 1
|
Height will be measured with a wall mounted tape measure and according to the ISAK recommendations |
Year 1
|
|
Height (cm).
Időkeret: Year 2
|
Height will be measured with a wall mounted tape measure and according to the ISAK recommendations |
Year 2
|
|
Height (cm).
Időkeret: Year 5
|
Height will be measured with a wall mounted tape measure and according to the ISAK recommendations |
Year 5
|
|
Body fat percentage (%).
Időkeret: Day 0
|
Body fat percentage will be measured with the Harpenden skinfold caliper by measuring skinfold thickness in four different sites (triceps; biceps, suprailiac, subscapular). |
Day 0
|
|
Body fat percentage (%).
Időkeret: Month 6
|
Body fat percentage will be measured with the Harpenden skinfold caliper by measuring skinfold thickness in four different sites (triceps; biceps, suprailiac, subscapular). |
Month 6
|
|
Body fat percentage (%).
Időkeret: Year 1
|
Body fat percentage will be measured with the Harpenden skinfold caliper by measuring skinfold thickness in four different sites (triceps; biceps, suprailiac, subscapular). |
Year 1
|
|
Body fat percentage (%).
Időkeret: Year 2
|
Body fat percentage will be measured with the Harpenden skinfold caliper by measuring skinfold thickness in four different sites (triceps; biceps, suprailiac, subscapular). |
Year 2
|
|
Body fat percentage (%).
Időkeret: Year 5
|
Body fat percentage will be measured with the Harpenden skinfold caliper by measuring skinfold thickness in four different sites (triceps; biceps, suprailiac, subscapular). |
Year 5
|
|
Waist circumference (cm).
Időkeret: Day 0
|
Waist circumference will be measured with a medical body tape measure and according to the ISAK recommendations |
Day 0
|
|
Waist circumference (cm).
Időkeret: Month 5
|
Waist circumference will be measured with a medical body tape measure and according to the ISAK recommendations |
Month 5
|
|
Waist circumference (cm).
Időkeret: Year 1
|
Waist circumference will be measured with a medical body tape measure and according to the ISAK recommendations |
Year 1
|
|
Waist circumference (cm).
Időkeret: Year 2
|
Waist circumference will be measured with a medical body tape measure and according to the ISAK recommendations |
Year 2
|
|
Waist circumference (cm).
Időkeret: Year 5
|
Waist circumference will be measured with a medical body tape measure and according to the ISAK recommendations |
Year 5
|
|
Hip circumference (cm).
Időkeret: Day 0
|
Hip circumference will be measured with a medical body tape measure and according to the ISAK recommendations. |
Day 0
|
|
Hip circumference (cm).
Időkeret: Month 6
|
Hip circumference will be measured with a medical body tape measure and according to the ISAK recommendations. |
Month 6
|
|
Hip circumference (cm).
Időkeret: Year 1
|
Hip circumference will be measured with a medical body tape measure and according to the ISAK recommendations. |
Year 1
|
|
Hip circumference (cm).
Időkeret: Year 2
|
Hip circumference will be measured with a medical body tape measure and according to the ISAK recommendations. |
Year 2
|
|
Hip circumference (cm).
Időkeret: Year 5
|
Hip circumference will be measured with a medical body tape measure and according to the ISAK recommendations. |
Year 5
|
|
Brachial circumference (cm).
Időkeret: Day 0
|
Brachial circumference will be measured with a medical body tape measure and according to the ISAK recommendations. |
Day 0
|
|
Brachial circumference (cm).
Időkeret: Month 6
|
Brachial circumference will be measured with a medical body tape measure and according to the ISAK recommendations. |
Month 6
|
|
Brachial circumference (cm).
Időkeret: Year 1
|
Brachial circumference will be measured with a medical body tape measure and according to the ISAK recommendations. |
Year 1
|
|
Brachial circumference (cm).
Időkeret: Year 2
|
Brachial circumference will be measured with a medical body tape measure and according to the ISAK recommendations. |
Year 2
|
|
Brachial circumference (cm).
Időkeret: Year 5
|
Brachial circumference will be measured with a medical body tape measure and according to the ISAK recommendations. |
Year 5
|
|
Calf circumference (cm).
Időkeret: Day 0
|
Calf circumference will be measured with a medical body tape measure and according to the ISAK recommendations |
Day 0
|
|
Calf circumference (cm).
Időkeret: Month 6
|
Calf circumference will be measured with a medical body tape measure and according to the ISAK recommendations |
Month 6
|
|
Calf circumference (cm).
Időkeret: Year 1
|
Calf circumference will be measured with a medical body tape measure and according to the ISAK recommendations |
Year 1
|
|
Calf circumference (cm).
Időkeret: Year 2
|
Calf circumference will be measured with a medical body tape measure and according to the ISAK recommendations |
Year 2
|
|
Calf circumference (cm).
Időkeret: Year 5
|
Calf circumference will be measured with a medical body tape measure and according to the ISAK recommendations |
Year 5
|
|
Body Mass Index (Kg/m²).
Időkeret: Day 0
|
BMI will be calculated (weight in kilograms divided by height in meters squared). |
Day 0
|
|
Body Mass Index (Kg/m²).
Időkeret: Month 6
|
BMI will be calculated (weight in kilograms divided by height in meters squared). |
Month 6
|
|
Body Mass Index (Kg/m²).
Időkeret: Year 1
|
BMI will be calculated (weight in kilograms divided by height in meters squared). |
Year 1
|
|
Body Mass Index (Kg/m²).
Időkeret: Year 2
|
BMI will be calculated (weight in kilograms divided by height in meters squared). |
Year 2
|
|
Body Mass Index (Kg/m²).
Időkeret: Year 5
|
BMI will be calculated (weight in kilograms divided by height in meters squared). |
Year 5
|
|
Body composition
Időkeret: Day 0
|
Body composition (muscle and fat) will be measured using he Bodystat® Impedance-meter. |
Day 0
|
|
Body composition
Időkeret: Month 6
|
Body composition (muscle and fat) will be measured using he Bodystat® Impedance-meter. |
Month 6
|
|
Body composition
Időkeret: Year 1
|
Body composition (muscle and fat) will be measured using he Bodystat® Impedance-meter. |
Year 1
|
|
Body composition
Időkeret: Year 2
|
Body composition (muscle and fat) will be measured using he Bodystat® Impedance-meter. |
Year 2
|
|
Body composition
Időkeret: Year 5
|
Body composition (muscle and fat) will be measured using he Bodystat® Impedance-meter. |
Year 5
|
|
T-score (DS).
Időkeret: DAy 0
|
- Description: T-score will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. |
DAy 0
|
|
T-score (DS).
Időkeret: Month 6
|
- Description: T-score will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. |
Month 6
|
|
T-score (DS).
Időkeret: Year 1
|
- Description: T-score will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. |
Year 1
|
|
T-score (DS).
Időkeret: Year 2
|
- Description: T-score will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. |
Year 2
|
|
T-score (DS).
Időkeret: Year 5
|
- Description: T-score will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. |
Year 5
|
|
Z-score (DS).
Időkeret: Day 0
|
Z-score will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer |
Day 0
|
|
Z-score (DS).
Időkeret: Month 6
|
Z-score will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer |
Month 6
|
|
Z-score (DS).
Időkeret: Year 1
|
Z-score will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer |
Year 1
|
|
Z-score (DS).
Időkeret: Year 2
|
Z-score will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer |
Year 2
|
|
Z-score (DS).
Időkeret: Year 5
|
Z-score will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer |
Year 5
|
|
Fat mass
Időkeret: Day 0
|
Fat mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. |
Day 0
|
|
Fat mass
Időkeret: Month 6
|
Fat mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. |
Month 6
|
|
Fat mass
Időkeret: Year 1
|
Fat mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. |
Year 1
|
|
Fat mass
Időkeret: Year 2
|
Fat mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. |
Year 2
|
|
Fat mass
Időkeret: Year 5
|
Fat mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. |
Year 5
|
|
Fat-free mass (%).
Időkeret: Day 0
|
: Fat free mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. |
Day 0
|
|
Fat-free mass (%).
Időkeret: Month 6
|
: Fat free mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. |
Month 6
|
|
Fat-free mass (%).
Időkeret: Year 1
|
: Fat free mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. |
Year 1
|
|
Fat-free mass (%).
Időkeret: Year 2
|
: Fat free mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. |
Year 2
|
|
Fat-free mass (%).
Időkeret: Year 5
|
: Fat free mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. |
Year 5
|
|
Fat mas index (Kg/m²).
Időkeret: Day 0
|
Fat mas index will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. |
Day 0
|
|
Fat mas index (Kg/m²).
Időkeret: Month 6
|
Fat mas index will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. |
Month 6
|
|
Fat mas index (Kg/m²).
Időkeret: Year 1
|
Fat mas index will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. |
Year 1
|
|
Fat mas index (Kg/m²).
Időkeret: Year 2
|
Fat mas index will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. |
Year 2
|
|
Fat mas index (Kg/m²).
Időkeret: Year 5
|
Fat mas index will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. |
Year 5
|
|
Ratio of android to gynoid fat mass.
Időkeret: Day 0
|
Ratio of android to gynoid fat mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer |
Day 0
|
|
Ratio of android to gynoid fat mass.
Időkeret: Month 6
|
Ratio of android to gynoid fat mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer |
Month 6
|
|
Ratio of android to gynoid fat mass.
Időkeret: Year 1
|
Ratio of android to gynoid fat mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer |
Year 1
|
|
Ratio of android to gynoid fat mass.
Időkeret: Year 2
|
Ratio of android to gynoid fat mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer |
Year 2
|
|
Ratio of android to gynoid fat mass.
Időkeret: Year 5
|
Ratio of android to gynoid fat mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer |
Year 5
|
|
Visceral adipose tissue (Kg).
Időkeret: Day 0
|
Visceral fat mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. |
Day 0
|
|
Visceral adipose tissue (Kg).
Időkeret: Month 6
|
Visceral fat mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. |
Month 6
|
|
Visceral adipose tissue (Kg).
Időkeret: Year 1
|
Visceral fat mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. |
Year 1
|
|
Visceral adipose tissue (Kg).
Időkeret: Year 2
|
Visceral fat mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. |
Year 2
|
|
Visceral adipose tissue (Kg).
Időkeret: Year 5
|
Visceral fat mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. |
Year 5
|
|
Fat-free mass index (kg/m²).
Időkeret: Day 0
|
: Fat-free mass index will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. |
Day 0
|
|
Fat-free mass index (kg/m²).
Időkeret: Month 6
|
: Fat-free mass index will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. |
Month 6
|
|
Fat-free mass index (kg/m²).
Időkeret: Year 1
|
: Fat-free mass index will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. |
Year 1
|
|
Fat-free mass index (kg/m²).
Időkeret: Year 2
|
: Fat-free mass index will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. |
Year 2
|
|
Fat-free mass index (kg/m²).
Időkeret: Year 5
|
: Fat-free mass index will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. |
Year 5
|
|
Appendicular fat-free mass index (Kg/m²).
Időkeret: Day 0
|
Appendicular fat-free mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. |
Day 0
|
|
Appendicular fat-free mass index (Kg/m²).
Időkeret: Month 6
|
Appendicular fat-free mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. |
Month 6
|
|
Appendicular fat-free mass index (Kg/m²).
Időkeret: Year 1
|
Appendicular fat-free mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. |
Year 1
|
|
Appendicular fat-free mass index (Kg/m²).
Időkeret: Year 2
|
Appendicular fat-free mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. |
Year 2
|
|
Appendicular fat-free mass index (Kg/m²).
Időkeret: Year 5
|
Appendicular fat-free mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. |
Year 5
|
|
Bone mass (Kg)
Időkeret: Day 0
|
- Description: Bone mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. |
Day 0
|
|
Bone mass (Kg)
Időkeret: Month 6
|
- Description: Bone mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. |
Month 6
|
|
Bone mass (Kg)
Időkeret: Year 1
|
- Description: Bone mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. |
Year 1
|
|
Bone mass (Kg)
Időkeret: Year 2
|
- Description: Bone mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. |
Year 2
|
|
Bone mass (Kg)
Időkeret: Year 5
|
- Description: Bone mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. |
Year 5
|
|
Daily caloric intake (Kcal/24h).
Időkeret: Day 0
|
Daily caloric intake will be estimated with a 24-hour (all foods and beverages consumed by the respondent in the past 24 hours). |
Day 0
|
|
Daily caloric intake (Kcal/24h).
Időkeret: Month 6
|
Daily caloric intake will be estimated with a 24-hour (all foods and beverages consumed by the respondent in the past 24 hours). |
Month 6
|
|
Daily caloric intake (Kcal/24h).
Időkeret: Year 1
|
Daily caloric intake will be estimated with a 24-hour (all foods and beverages consumed by the respondent in the past 24 hours). |
Year 1
|
|
Daily caloric intake (Kcal/24h).
Időkeret: Year 2
|
Daily caloric intake will be estimated with a 24-hour (all foods and beverages consumed by the respondent in the past 24 hours). |
Year 2
|
|
Daily caloric intake (Kcal/24h).
Időkeret: Year 5
|
Daily caloric intake will be estimated with a 24-hour (all foods and beverages consumed by the respondent in the past 24 hours). |
Year 5
|
|
Daily protein intake (in g and as a percentage of total caloric intake).
Időkeret: Day 0
|
Daily protein intake will be estimated with a 24-hour (all foods and beverages consumed by the respondent in the past 24 hours). |
Day 0
|
|
Daily protein intake (in g and as a percentage of total caloric intake).
Időkeret: Month 6
|
Daily protein intake (in g and as a percentage of total caloric intake). |
Month 6
|
|
Daily protein intake (in g and as a percentage of total caloric intake).
Időkeret: Year 1
|
Daily protein intake will be estimated with a 24-hour (all foods and beverages consumed by the respondent in the past 24 hours). |
Year 1
|
|
Daily protein intake (in g and as a percentage of total caloric intake).
Időkeret: Year 2
|
Daily protein intake will be estimated with a 24-hour (all foods and beverages consumed by the respondent in the past 24 hours). |
Year 2
|
|
Daily protein intake (in g and as a percentage of total caloric intake).
Időkeret: Year 5
|
Daily protein intake will be estimated with a 24-hour (all foods and beverages consumed by the respondent in the past 24 hours). |
Year 5
|
|
Daily carbohydrate intake (in g and as a percentage of total caloric intake).
Időkeret: Day 0
|
Daily carbohydrate intake will be estimated with a 24-hour (all foods and beverages consumed by the respondent in the past 24 hours). |
Day 0
|
|
Daily carbohydrate intake (in g and as a percentage of total caloric intake).
Időkeret: Month 6
|
Daily carbohydrate intake will be estimated with a 24-hour (all foods and beverages consumed by the respondent in the past 24 hours). |
Month 6
|
|
Daily carbohydrate intake (in g and as a percentage of total caloric intake).
Időkeret: Year 1
|
Daily carbohydrate intake will be estimated with a 24-hour (all foods and beverages consumed by the respondent in the past 24 hours). |
Year 1
|
|
Daily carbohydrate intake (in g and as a percentage of total caloric intake).
Időkeret: Year 2
|
Daily carbohydrate intake will be estimated with a 24-hour (all foods and beverages consumed by the respondent in the past 24 hours). |
Year 2
|
|
Daily carbohydrate intake (in g and as a percentage of total caloric intake).
Időkeret: Year 5
|
Daily carbohydrate intake will be estimated with a 24-hour (all foods and beverages consumed by the respondent in the past 24 hours). |
Year 5
|
|
Daily fat intake (in g and as a percentage of total caloric intake).
Időkeret: Day 0
|
Daily fat intake will be estimated with a 24-hour (all foods and beverages consumed by the respondent in the past 24 hours). |
Day 0
|
|
Daily fat intake (in g and as a percentage of total caloric intake).
Időkeret: Month 6
|
Daily fat intake will be estimated with a 24-hour (all foods and beverages consumed by the respondent in the past 24 hours). |
Month 6
|
|
Daily fat intake (in g and as a percentage of total caloric intake).
Időkeret: Year 1
|
Daily fat intake will be estimated with a 24-hour (all foods and beverages consumed by the respondent in the past 24 hours). |
Year 1
|
|
Daily fat intake (in g and as a percentage of total caloric intake).
Időkeret: Year 2
|
Daily fat intake will be estimated with a 24-hour (all foods and beverages consumed by the respondent in the past 24 hours). |
Year 2
|
|
Daily fat intake (in g and as a percentage of total caloric intake).
Időkeret: Year 5
|
Daily fat intake will be estimated with a 24-hour (all foods and beverages consumed by the respondent in the past 24 hours). |
Year 5
|
|
Nutritional status assessment
Időkeret: Day 0
|
Nutritional status assessment will be assessed with the Mini Nutritional Assessment Questionnaire. |
Day 0
|
|
Nutritional status assessment
Időkeret: Month 6
|
Nutritional status assessment will be assessed with the Mini Nutritional Assessment Questionnaire. |
Month 6
|
|
Nutritional status assessment
Időkeret: Year 1
|
Nutritional status assessment will be assessed with the Mini Nutritional Assessment Questionnaire. |
Year 1
|
|
Nutritional status assessment
Időkeret: Year 2
|
Nutritional status assessment will be assessed with the Mini Nutritional Assessment Questionnaire. |
Year 2
|
|
Nutritional status assessment
Időkeret: Year 5
|
Nutritional status assessment will be assessed with the Mini Nutritional Assessment Questionnaire. |
Year 5
|
|
Risk of undernutrition.
Időkeret: Day 0
|
Risk of undernutrition will be assessed with the Brocker Questionnaire |
Day 0
|
|
Risk of undernutrition.
Időkeret: Month 6
|
Risk of undernutrition will be assessed with the Brocker Questionnaire |
Month 6
|
|
Risk of undernutrition.
Időkeret: Year 1
|
Risk of undernutrition will be assessed with the Brocker Questionnaire |
Year 1
|
|
Risk of undernutrition.
Időkeret: Year 2
|
Risk of undernutrition will be assessed with the Brocker Questionnaire |
Year 2
|
|
Risk of undernutrition.
Időkeret: Year 5
|
Risk of undernutrition will be assessed with the Brocker Questionnaire |
Year 5
|
|
Basic biology.
Időkeret: Day 0
|
: Basic biology will be measured using endocrine assays (fasting blood glucose, HbA1c, HDL-c and LDL-c, TG, CPK) |
Day 0
|
|
Basic biology.
Időkeret: Month 6
|
: Basic biology will be measured using endocrine assays (fasting blood glucose, HbA1c, HDL-c and LDL-c, TG, CPK) |
Month 6
|
|
Basic biology.
Időkeret: Year 1
|
: Basic biology will be measured using endocrine assays (fasting blood glucose, HbA1c, HDL-c and LDL-c, TG, CPK) |
Year 1
|
|
Basic biology.
Időkeret: Year 2
|
: Basic biology will be measured using endocrine assays (fasting blood glucose, HbA1c, HDL-c and LDL-c, TG, CPK) |
Year 2
|
|
Basic biology.
Időkeret: Year 5
|
: Basic biology will be measured using endocrine assays (fasting blood glucose, HbA1c, HDL-c and LDL-c, TG, CPK) |
Year 5
|
|
Maximum voluntary isometric strength of the quadriceps muscles at 45° (Nm).
Időkeret: Day 0
|
: Maximum voluntary isometric strength of the quadriceps muscles will be measured with the HUMA® /NORM™ device. |
Day 0
|
|
Maximum voluntary isometric strength of the quadriceps muscles at 45° (Nm).
Időkeret: Month 6
|
: Maximum voluntary isometric strength of the quadriceps muscles will be measured with the HUMA® /NORM™ device. |
Month 6
|
|
Maximum voluntary isometric strength of the quadriceps muscles at 45° (Nm).
Időkeret: Year 1
|
: Maximum voluntary isometric strength of the quadriceps muscles will be measured with the HUMA® /NORM™ device. |
Year 1
|
|
Maximum voluntary isometric strength of the quadriceps muscles at 45° (Nm).
Időkeret: Year 2
|
: Maximum voluntary isometric strength of the quadriceps muscles will be measured with the HUMA® /NORM™ device. |
Year 2
|
|
Maximum voluntary isometric strength of the quadriceps muscles at 45° (Nm).
Időkeret: Year 5
|
: Maximum voluntary isometric strength of the quadriceps muscles will be measured with the HUMA® /NORM™ device. |
Year 5
|
|
Maximum voluntary isokinetic strength of the quadriceps muscles at 60°/s (Nm).
Időkeret: Day 0
|
- Description: Maximum voluntary isokinetic strength of the quadriceps muscles at 60°/s will be measured with the HUMA® /NORM™ device. |
Day 0
|
|
Maximum voluntary isokinetic strength of the quadriceps muscles at 60°/s (Nm).
Időkeret: Month 6
|
- Description: Maximum voluntary isokinetic strength of the quadriceps muscles at 60°/s will be measured with the HUMA® /NORM™ device. |
Month 6
|
|
Maximum voluntary isokinetic strength of the quadriceps muscles at 60°/s (Nm).
Időkeret: Year 1
|
- Description: Maximum voluntary isokinetic strength of the quadriceps muscles at 60°/s will be measured with the HUMA® /NORM™ device. |
Year 1
|
|
Maximum voluntary isokinetic strength of the quadriceps muscles at 60°/s (Nm).
Időkeret: Year 2
|
- Description: Maximum voluntary isokinetic strength of the quadriceps muscles at 60°/s will be measured with the HUMA® /NORM™ device. |
Year 2
|
|
Maximum voluntary isokinetic strength of the quadriceps muscles at 60°/s (Nm).
Időkeret: Year 5
|
- Description: Maximum voluntary isokinetic strength of the quadriceps muscles at 60°/s will be measured with the HUMA® /NORM™ device. |
Year 5
|
|
Maximum voluntary isokinetic strength of the quadriceps muscles at 240°/s (Nm).
Időkeret: Day 0
|
Maximum voluntary isokinetic strength of the quadriceps muscles at 240°/s will be measured with the HUMA® /NORM™ device. |
Day 0
|
|
Maximum voluntary isokinetic strength of the quadriceps muscles at 240°/s (Nm).
Időkeret: Month 6
|
Maximum voluntary isokinetic strength of the quadriceps muscles at 240°/s will be measured with the HUMA® /NORM™ device. |
Month 6
|
|
Maximum voluntary isokinetic strength of the quadriceps muscles at 240°/s (Nm).
Időkeret: Year 1
|
Maximum voluntary isokinetic strength of the quadriceps muscles at 240°/s will be measured with the HUMA® /NORM™ device. |
Year 1
|
|
Maximum voluntary isokinetic strength of the quadriceps muscles at 240°/s (Nm).
Időkeret: Year 2
|
Maximum voluntary isokinetic strength of the quadriceps muscles at 240°/s will be measured with the HUMA® /NORM™ device. |
Year 2
|
|
Maximum voluntary isokinetic strength of the quadriceps muscles at 240°/s (Nm).
Időkeret: Year 5
|
Maximum voluntary isokinetic strength of the quadriceps muscles at 240°/s will be measured with the HUMA® /NORM™ device. |
Year 5
|
|
Maximum voluntary isokinetic strength of the quadriceps muscles at 30°/s (eccentric contraction) (Nm).
Időkeret: Day 0
|
Maximum voluntary isokinetic strength of the quadriceps muscles at 30°/s will be measured with the HUMA® /NORM™ device. |
Day 0
|
|
Maximum voluntary isokinetic strength of the quadriceps muscles at 30°/s (eccentric contraction) (Nm).
Időkeret: Month 6
|
Maximum voluntary isokinetic strength of the quadriceps muscles at 30°/s will be measured with the HUMA® /NORM™ device. |
Month 6
|
|
Maximum voluntary isokinetic strength of the quadriceps muscles at 30°/s (eccentric contraction) (Nm).
Időkeret: Year 1
|
Maximum voluntary isokinetic strength of the quadriceps muscles at 30°/s will be measured with the HUMA® /NORM™ device. |
Year 1
|
|
Maximum voluntary isokinetic strength of the quadriceps muscles at 30°/s (eccentric contraction) (Nm).
Időkeret: Year 2
|
Maximum voluntary isokinetic strength of the quadriceps muscles at 30°/s will be measured with the HUMA® /NORM™ device. |
Year 2
|
|
Maximum voluntary isokinetic strength of the quadriceps muscles at 30°/s (eccentric contraction) (Nm).
Időkeret: Year 5
|
Maximum voluntary isokinetic strength of the quadriceps muscles at 30°/s will be measured with the HUMA® /NORM™ device. |
Year 5
|
|
Maximum voluntary isokinetic strength of the hamstring muscles at 60°/s (Nm).
Időkeret: Day 0
|
Maximum voluntary isokinetic strength of the hamstring muscles at 60°/s will be measured with the HUMA® /NORM™ device. |
Day 0
|
|
Maximum voluntary isokinetic strength of the hamstring muscles at 60°/s (Nm).
Időkeret: Month 6
|
Maximum voluntary isokinetic strength of the hamstring muscles at 60°/s will be measured with the HUMA® /NORM™ device. |
Month 6
|
|
Maximum voluntary isokinetic strength of the hamstring muscles at 60°/s (Nm).
Időkeret: Year 1
|
Maximum voluntary isokinetic strength of the hamstring muscles at 60°/s will be measured with the HUMA® /NORM™ device. |
Year 1
|
|
Maximum voluntary isokinetic strength of the hamstring muscles at 60°/s (Nm).
Időkeret: Year 2
|
Maximum voluntary isokinetic strength of the hamstring muscles at 60°/s will be measured with the HUMA® /NORM™ device. |
Year 2
|
|
Maximum voluntary isokinetic strength of the hamstring muscles at 60°/s (Nm).
Időkeret: Year 5
|
Maximum voluntary isokinetic strength of the hamstring muscles at 60°/s will be measured with the HUMA® /NORM™ device. |
Year 5
|
|
Maximum voluntary isokinetic strength of the hamstring muscles at 240°/s (Nm).
Időkeret: Day 0
|
- Description: Maximum voluntary isokinetic strength of the hamstring muscles at 240°/s will be measured with the HUMA® /NORM™ device. |
Day 0
|
|
Maximum voluntary isokinetic strength of the hamstring muscles at 240°/s (Nm).
Időkeret: Month 6
|
- Description: Maximum voluntary isokinetic strength of the hamstring muscles at 240°/s will be measured with the HUMA® /NORM™ device. |
Month 6
|
|
Maximum voluntary isokinetic strength of the hamstring muscles at 240°/s (Nm).
Időkeret: Year 1
|
- Description: Maximum voluntary isokinetic strength of the hamstring muscles at 240°/s will be measured with the HUMA® /NORM™ device. |
Year 1
|
|
Maximum voluntary isokinetic strength of the hamstring muscles at 240°/s (Nm).
Időkeret: Year 2
|
- Description: Maximum voluntary isokinetic strength of the hamstring muscles at 240°/s will be measured with the HUMA® /NORM™ device. |
Year 2
|
|
Maximum voluntary isokinetic strength of the hamstring muscles at 240°/s (Nm).
Időkeret: Year 5
|
- Description: Maximum voluntary isokinetic strength of the hamstring muscles at 240°/s will be measured with the HUMA® /NORM™ device. |
Year 5
|
|
Maximum voluntary isokinetic strength of the hamstring muscles at 30°/s (eccentric contraction) (Nm).
Időkeret: Day 0
|
Maximum voluntary isokinetic strength of the hamstring muscles at 30°/s will be measured with the HUMA® /NORM™ device. |
Day 0
|
|
Maximum voluntary isokinetic strength of the hamstring muscles at 30°/s (eccentric contraction) (Nm).
Időkeret: Month 6
|
Maximum voluntary isokinetic strength of the hamstring muscles at 30°/s will be measured with the HUMA® /NORM™ device. |
Month 6
|
|
Maximum voluntary isokinetic strength of the hamstring muscles at 30°/s (eccentric contraction) (Nm).
Időkeret: Year 1
|
Maximum voluntary isokinetic strength of the hamstring muscles at 30°/s will be measured with the HUMA® /NORM™ device. |
Year 1
|
|
Maximum voluntary isokinetic strength of the hamstring muscles at 30°/s (eccentric contraction) (Nm).
Időkeret: Year 2
|
Maximum voluntary isokinetic strength of the hamstring muscles at 30°/s will be measured with the HUMA® /NORM™ device. |
Year 2
|
|
Maximum voluntary isokinetic strength of the hamstring muscles at 30°/s (eccentric contraction) (Nm).
Időkeret: Year 5
|
Maximum voluntary isokinetic strength of the hamstring muscles at 30°/s will be measured with the HUMA® /NORM™ device. |
Year 5
|
|
Endurance coefficient of the quadriceps muscles at 180°/s.
Időkeret: Day 0
|
Endurance coefficient will be estimated as a Σ Peak torque ratio of the last 3 contractions on the first 3 at 180°/s with the HUMA® /NORM™ device. |
Day 0
|
|
Endurance coefficient of the quadriceps muscles at 180°/s.
Időkeret: Month 6
|
Endurance coefficient will be estimated as a Σ Peak torque ratio of the last 3 contractions on the first 3 at 180°/s with the HUMA® /NORM™ device. |
Month 6
|
|
Endurance coefficient of the quadriceps muscles at 180°/s.
Időkeret: Year 1
|
Endurance coefficient will be estimated as a Σ Peak torque ratio of the last 3 contractions on the first 3 at 180°/s with the HUMA® /NORM™ device. |
Year 1
|
|
Endurance coefficient of the quadriceps muscles at 180°/s.
Időkeret: Year 2
|
Endurance coefficient will be estimated as a Σ Peak torque ratio of the last 3 contractions on the first 3 at 180°/s with the HUMA® /NORM™ device. |
Year 2
|
|
Endurance coefficient of the quadriceps muscles at 180°/s.
Időkeret: Year 5
|
Endurance coefficient will be estimated as a Σ Peak torque ratio of the last 3 contractions on the first 3 at 180°/s with the HUMA® /NORM™ device. |
Year 5
|
|
Endurance coefficient of the hamstring muscles at 180°/s.
Időkeret: Day 0
|
Endurance coefficient will be estimated as a Σ Peak torque ratio of the last 3 contractions on the first 3 at 180°/s with the HUMA® /NORM™ device.. |
Day 0
|
|
Endurance coefficient of the hamstring muscles at 180°/s.
Időkeret: Month 6
|
Endurance coefficient will be estimated as a Σ Peak torque ratio of the last 3 contractions on the first 3 at 180°/s with the HUMA® /NORM™ device.. |
Month 6
|
|
Endurance coefficient of the hamstring muscles at 180°/s.
Időkeret: Year 1
|
Endurance coefficient will be estimated as a Σ Peak torque ratio of the last 3 contractions on the first 3 at 180°/s with the HUMA® /NORM™ device.. |
Year 1
|
|
Endurance coefficient of the hamstring muscles at 180°/s.
Időkeret: Year 2
|
Endurance coefficient will be estimated as a Σ Peak torque ratio of the last 3 contractions on the first 3 at 180°/s with the HUMA® /NORM™ device.. |
Year 2
|
|
Endurance coefficient of the hamstring muscles at 180°/s.
Időkeret: Year 5
|
Endurance coefficient will be estimated as a Σ Peak torque ratio of the last 3 contractions on the first 3 at 180°/s with the HUMA® /NORM™ device.. |
Year 5
|
|
Functional ratio
Időkeret: Day 0
|
Functional ratio will be estimated by dividing the maximum voluntary isokinetic strength of the hamstring muscles at 60°/s with the maximum voluntary isokinetic strength of the quadriceps muscles at 60°/s. |
Day 0
|
|
Functional ratio
Időkeret: Month 6
|
Functional ratio will be estimated by dividing the maximum voluntary isokinetic strength of the hamstring muscles at 60°/s with the maximum voluntary isokinetic strength of the quadriceps muscles at 60°/s. |
Month 6
|
|
Functional ratio
Időkeret: Year 1
|
Functional ratio will be estimated by dividing the maximum voluntary isokinetic strength of the hamstring muscles at 60°/s with the maximum voluntary isokinetic strength of the quadriceps muscles at 60°/s. |
Year 1
|
|
Functional ratio
Időkeret: Year 2
|
Functional ratio will be estimated by dividing the maximum voluntary isokinetic strength of the hamstring muscles at 60°/s with the maximum voluntary isokinetic strength of the quadriceps muscles at 60°/s. |
Year 2
|
|
Functional ratio
Időkeret: Year 5
|
Functional ratio will be estimated by dividing the maximum voluntary isokinetic strength of the hamstring muscles at 60°/s with the maximum voluntary isokinetic strength of the quadriceps muscles at 60°/s. |
Year 5
|
|
Mixed ratio
Időkeret: Day 0
|
- Mixed ratio will be estimated by dividing the maximum voluntary isokinetic strength of the hamstring muscles at 30°/s (eccentric contraction) with the maximum voluntary isokinetic strength of the quadriceps muscles at 240°/s Title: Maximum voluntary strength of the quadriceps muscles at 60°/s. |
Day 0
|
|
Mixed ratio
Időkeret: Month 6
|
- Mixed ratio will be estimated by dividing the maximum voluntary isokinetic strength of the hamstring muscles at 30°/s (eccentric contraction) with the maximum voluntary isokinetic strength of the quadriceps muscles at 240°/s Title: Maximum voluntary strength of the quadriceps muscles at 60°/s. |
Month 6
|
|
Mixed ratio
Időkeret: Year 1
|
- Mixed ratio will be estimated by dividing the maximum voluntary isokinetic strength of the hamstring muscles at 30°/s (eccentric contraction) with the maximum voluntary isokinetic strength of the quadriceps muscles at 240°/s Title: Maximum voluntary strength of the quadriceps muscles at 60°/s. |
Year 1
|
|
Mixed ratio
Időkeret: Year 2
|
- Mixed ratio will be estimated by dividing the maximum voluntary isokinetic strength of the hamstring muscles at 30°/s (eccentric contraction) with the maximum voluntary isokinetic strength of the quadriceps muscles at 240°/s Title: Maximum voluntary strength of the quadriceps muscles at 60°/s. |
Year 2
|
|
Mixed ratio
Időkeret: Year 5
|
- Mixed ratio will be estimated by dividing the maximum voluntary isokinetic strength of the hamstring muscles at 30°/s (eccentric contraction) with the maximum voluntary isokinetic strength of the quadriceps muscles at 240°/s Title: Maximum voluntary strength of the quadriceps muscles at 60°/s. |
Year 5
|
|
Maximum voluntary hand grip strength (Kg).
Időkeret: Day 0
|
Maximum voluntary hand grip strength will be measured with the Jamar® hydraulic dynamometer and with the Baseline® pneumatic dynamometer. |
Day 0
|
|
Maximum voluntary hand grip strength (Kg).
Időkeret: Month 6
|
Maximum voluntary hand grip strength will be measured with the Jamar® hydraulic dynamometer and with the Baseline® pneumatic dynamometer. |
Month 6
|
|
Maximum voluntary hand grip strength (Kg).
Időkeret: Year 1
|
Maximum voluntary hand grip strength will be measured with the Jamar® hydraulic dynamometer and with the Baseline® pneumatic dynamometer. |
Year 1
|
|
Maximum voluntary hand grip strength (Kg).
Időkeret: Year 2
|
Maximum voluntary hand grip strength will be measured with the Jamar® hydraulic dynamometer and with the Baseline® pneumatic dynamometer. |
Year 2
|
|
Maximum voluntary hand grip strength (Kg).
Időkeret: Year 5
|
Maximum voluntary hand grip strength will be measured with the Jamar® hydraulic dynamometer and with the Baseline® pneumatic dynamometer. |
Year 5
|
|
Maximum voluntary pinch strength (Kg).
Időkeret: Day 0
|
Maximum voluntary pinch strength will be measured with the Baseline® pinch gauche test mechanical dynamometer. |
Day 0
|
|
Maximum voluntary pinch strength (Kg).
Időkeret: Month 6
|
Maximum voluntary pinch strength will be measured with the Baseline® pinch gauche test mechanical dynamometer. |
Month 6
|
|
Maximum voluntary pinch strength (Kg).
Időkeret: Year 1
|
Maximum voluntary pinch strength will be measured with the Baseline® pinch gauche test mechanical dynamometer. |
Year 1
|
|
Maximum voluntary pinch strength (Kg).
Időkeret: Year 2
|
Maximum voluntary pinch strength will be measured with the Baseline® pinch gauche test mechanical dynamometer. |
Year 2
|
|
Maximum voluntary pinch strength (Kg).
Időkeret: Year 5
|
Maximum voluntary pinch strength will be measured with the Baseline® pinch gauche test mechanical dynamometer. |
Year 5
|
|
Hip passive joint range
Időkeret: Day 0
|
Hip joint range will be measured with a medical goniometer. |
Day 0
|
|
Hip passive joint range
Időkeret: Month 6
|
Hip joint range will be measured with a medical goniometer. |
Month 6
|
|
Hip passive joint range
Időkeret: Year 1
|
Hip joint range will be measured with a medical goniometer. |
Year 1
|
|
Hip passive joint range
Időkeret: Year 2
|
Hip joint range will be measured with a medical goniometer. |
Year 2
|
|
Hip passive joint range
Időkeret: Year 5
|
Hip joint range will be measured with a medical goniometer. |
Year 5
|
|
Knee passive joint range.
Időkeret: Day 0
|
Knee joint range will be measured with a medical goniometer. |
Day 0
|
|
Knee passive joint range.
Időkeret: Month 6
|
Knee joint range will be measured with a medical goniometer. |
Month 6
|
|
Knee passive joint range.
Időkeret: Year 1
|
Knee joint range will be measured with a medical goniometer. |
Year 1
|
|
Knee passive joint range.
Időkeret: Year 2
|
Knee joint range will be measured with a medical goniometer. |
Year 2
|
|
Knee passive joint range.
Időkeret: Year 5
|
Knee joint range will be measured with a medical goniometer. |
Year 5
|
|
Ankle passive joint range
Időkeret: Day 0
|
Ankle joint range will be measured with a medical goniometer. |
Day 0
|
|
Ankle passive joint range
Időkeret: Month 6
|
Ankle joint range will be measured with a medical goniometer. |
Month 6
|
|
Ankle passive joint range
Időkeret: Year 1
|
Ankle joint range will be measured with a medical goniometer. |
Year 1
|
|
Ankle passive joint range
Időkeret: Year 2
|
Ankle joint range will be measured with a medical goniometer. |
Year 2
|
|
Ankle passive joint range
Időkeret: Year 5
|
Ankle joint range will be measured with a medical goniometer. |
Year 5
|
|
Lower and upper limb muscle power assessment (MRC)
Időkeret: Day 0
|
Lower and upper limb muscle power assessment will be performed by an experienced physician. |
Day 0
|
|
Lower and upper limb muscle power assessment (MRC)
Időkeret: Month 6
|
Lower and upper limb muscle power assessment will be performed by an experienced physician. |
Month 6
|
|
Lower and upper limb muscle power assessment (MRC)
Időkeret: Year 1
|
Lower and upper limb muscle power assessment will be performed by an experienced physician. |
Year 1
|
|
Lower and upper limb muscle power assessment (MRC)
Időkeret: Year 2
|
Lower and upper limb muscle power assessment will be performed by an experienced physician. |
Year 2
|
|
Lower and upper limb muscle power assessment (MRC)
Időkeret: Year 5
|
Lower and upper limb muscle power assessment will be performed by an experienced physician. |
Year 5
|
|
Statokinesigram surface area (mm²)
Időkeret: Day 0
|
Statokinesigram surface area will be measured with the STATIPRO® static posturography platform. |
Day 0
|
|
Statokinesigram surface area (mm²)
Időkeret: Month 6
|
Statokinesigram surface area will be measured with the STATIPRO® static posturography platform. |
Month 6
|
|
Statokinesigram surface area (mm²)
Időkeret: Year 1
|
Statokinesigram surface area will be measured with the STATIPRO® static posturography platform. |
Year 1
|
|
Statokinesigram surface area (mm²)
Időkeret: Year 2
|
Statokinesigram surface area will be measured with the STATIPRO® static posturography platform. |
Year 2
|
|
Statokinesigram surface area (mm²)
Időkeret: Year 5
|
Statokinesigram surface area will be measured with the STATIPRO® static posturography platform. |
Year 5
|
|
Stabilogram length (mm).
Időkeret: Day 0
|
Stabilogram length will be measured with the STATIPRO® static posturography platform |
Day 0
|
|
Stabilogram length (mm).
Időkeret: Month 6
|
Stabilogram length will be measured with the STATIPRO® static posturography platform |
Month 6
|
|
Stabilogram length (mm).
Időkeret: Year 1
|
Stabilogram length will be measured with the STATIPRO® static posturography platform |
Year 1
|
|
Stabilogram length (mm).
Időkeret: Year 2
|
Stabilogram length will be measured with the STATIPRO® static posturography platform |
Year 2
|
|
Stabilogram length (mm).
Időkeret: Year 5
|
Stabilogram length will be measured with the STATIPRO® static posturography platform |
Year 5
|
|
Maximal deflection (forward, backward left and right).
Időkeret: Day 0
|
Maximal deflection will be measured with the STATIPRO® static posturography platform. |
Day 0
|
|
Maximal deflection (forward, backward left and right).
Időkeret: Month 6
|
Maximal deflection will be measured with the STATIPRO® static posturography platform. |
Month 6
|
|
Maximal deflection (forward, backward left and right).
Időkeret: Year 1
|
Maximal deflection will be measured with the STATIPRO® static posturography platform. |
Year 1
|
|
Maximal deflection (forward, backward left and right).
Időkeret: Year 2
|
Maximal deflection will be measured with the STATIPRO® static posturography platform. |
Year 2
|
|
Maximal deflection (forward, backward left and right).
Időkeret: Year 5
|
Maximal deflection will be measured with the STATIPRO® static posturography platform. |
Year 5
|
|
Velocity variations (mm/s).
Időkeret: Day 0
|
: Velocity variations will be measured with the STATIPRO® static posturography platform. |
Day 0
|
|
Velocity variations (mm/s).
Időkeret: Month 6
|
: Velocity variations will be measured with the STATIPRO® static posturography platform. |
Month 6
|
|
Velocity variations (mm/s).
Időkeret: Year 1
|
: Velocity variations will be measured with the STATIPRO® static posturography platform. |
Year 1
|
|
Velocity variations (mm/s).
Időkeret: Year 2
|
: Velocity variations will be measured with the STATIPRO® static posturography platform. |
Year 2
|
|
Velocity variations (mm/s).
Időkeret: Year 5
|
: Velocity variations will be measured with the STATIPRO® static posturography platform. |
Year 5
|
|
: Romberg ratio according to sway area
Időkeret: Day 0
|
Romberg ratio will be measured with the STATIPRO® static posturography platform. |
Day 0
|
|
: Romberg ratio according to sway area
Időkeret: Month 6
|
Romberg ratio will be measured with the STATIPRO® static posturography platform. |
Month 6
|
|
: Romberg ratio according to sway area
Időkeret: Year 1
|
Romberg ratio will be measured with the STATIPRO® static posturography platform. |
Year 1
|
|
: Romberg ratio according to sway area
Időkeret: Year 2
|
Romberg ratio will be measured with the STATIPRO® static posturography platform. |
Year 2
|
|
: Romberg ratio according to sway area
Időkeret: Year 5
|
Romberg ratio will be measured with the STATIPRO® static posturography platform. |
Year 5
|
|
Romberg ratio according to center of pressure path length
Időkeret: Day 0
|
Romberg ratio will be measured with the STATIPRO® static posturography platform. |
Day 0
|
|
Romberg ratio according to center of pressure path length
Időkeret: Month 6
|
Romberg ratio will be measured with the STATIPRO® static posturography platform. |
Month 6
|
|
Romberg ratio according to center of pressure path length
Időkeret: Year 1
|
Romberg ratio will be measured with the STATIPRO® static posturography platform. |
Year 1
|
|
Romberg ratio according to center of pressure path length
Időkeret: Year 2
|
Romberg ratio will be measured with the STATIPRO® static posturography platform. |
Year 2
|
|
Romberg ratio according to center of pressure path length
Időkeret: Year 5
|
Romberg ratio will be measured with the STATIPRO® static posturography platform. |
Year 5
|
|
: Plantar pressure ratio sway area.
Időkeret: Day 0
|
Plantar pressure ratio sway area will be measured with the STATIPRO® static posturography platform. |
Day 0
|
|
: Plantar pressure ratio sway area.
Időkeret: Month 6
|
Plantar pressure ratio sway area will be measured with the STATIPRO® static posturography platform. |
Month 6
|
|
: Plantar pressure ratio sway area.
Időkeret: Year 1
|
Plantar pressure ratio sway area will be measured with the STATIPRO® static posturography platform. |
Year 1
|
|
: Plantar pressure ratio sway area.
Időkeret: Year 2
|
Plantar pressure ratio sway area will be measured with the STATIPRO® static posturography platform. |
Year 2
|
|
: Plantar pressure ratio sway area.
Időkeret: Year 5
|
Plantar pressure ratio sway area will be measured with the STATIPRO® static posturography platform. |
Year 5
|
|
Plantar pressure ratio length.
Időkeret: Day 0
|
Plantar pressure ratio length will be measured with the STATIPRO® static posturography platform. |
Day 0
|
|
Plantar pressure ratio length.
Időkeret: Month 6
|
Plantar pressure ratio length will be measured with the STATIPRO® static posturography platform. |
Month 6
|
|
Plantar pressure ratio length.
Időkeret: Year 1
|
Plantar pressure ratio length will be measured with the STATIPRO® static posturography platform. |
Year 1
|
|
Plantar pressure ratio length.
Időkeret: Year 2
|
Plantar pressure ratio length will be measured with the STATIPRO® static posturography platform. |
Year 2
|
|
Plantar pressure ratio length.
Időkeret: Year 5
|
Plantar pressure ratio length will be measured with the STATIPRO® static posturography platform. |
Year 5
|
|
Walking velocity (cm/s).
Időkeret: Day 0
|
Walking velocity will be measured with the GAITRite® Electronic Walkway. |
Day 0
|
|
Walking velocity (cm/s).
Időkeret: Month 6
|
Walking velocity will be measured with the GAITRite® Electronic Walkway. |
Month 6
|
|
Walking velocity (cm/s).
Időkeret: Year 1
|
Walking velocity will be measured with the GAITRite® Electronic Walkway. |
Year 1
|
|
Walking velocity (cm/s).
Időkeret: Year 2
|
Walking velocity will be measured with the GAITRite® Electronic Walkway. |
Year 2
|
|
Walking velocity (cm/s).
Időkeret: Year 5
|
Walking velocity will be measured with the GAITRite® Electronic Walkway. |
Year 5
|
|
Cadence (steps/min).
Időkeret: Day 0
|
: Cadence will be measured with the GAITRite® Electronic Walkway. |
Day 0
|
|
Cadence (steps/min).
Időkeret: Month 6
|
: Cadence will be measured with the GAITRite® Electronic Walkway. |
Month 6
|
|
Cadence (steps/min).
Időkeret: Year 1
|
: Cadence will be measured with the GAITRite® Electronic Walkway. |
Year 1
|
|
Cadence (steps/min).
Időkeret: Year 2
|
: Cadence will be measured with the GAITRite® Electronic Walkway. |
Year 2
|
|
Cadence (steps/min).
Időkeret: Year 5
|
: Cadence will be measured with the GAITRite® Electronic Walkway. |
Year 5
|
|
Step length (left and right foot) (cm)
Időkeret: DAy 0
|
Step length will be measured with the GAITRite® Electronic Walkway. |
DAy 0
|
|
Step length (left and right foot) (cm)
Időkeret: Month 6
|
Step length will be measured with the GAITRite® Electronic Walkway. |
Month 6
|
|
Step length (left and right foot) (cm)
Időkeret: Year 1
|
Step length will be measured with the GAITRite® Electronic Walkway. |
Year 1
|
|
Step length (left and right foot) (cm)
Időkeret: Year 2
|
Step length will be measured with the GAITRite® Electronic Walkway. |
Year 2
|
|
Step length (left and right foot) (cm)
Időkeret: Year 5
|
Step length will be measured with the GAITRite® Electronic Walkway. |
Year 5
|
|
Stride length (cm).
Időkeret: Day 0
|
Stride length will be measured with the GAITRite® Electronic Walkway. |
Day 0
|
|
Stride length (cm).
Időkeret: month 6
|
Stride length will be measured with the GAITRite® Electronic Walkway. |
month 6
|
|
Stride length (cm).
Időkeret: year 1
|
Stride length will be measured with the GAITRite® Electronic Walkway. |
year 1
|
|
Stride length (cm).
Időkeret: year 2
|
Stride length will be measured with the GAITRite® Electronic Walkway. |
year 2
|
|
Stride length (cm).
Időkeret: year 5
|
Stride length will be measured with the GAITRite® Electronic Walkway. |
year 5
|
|
Single support time left and right foot (s).
Időkeret: Day 0
|
Single support time will be measured with the GAITRite® Electronic Walkway. |
Day 0
|
|
Single support time left and right foot (s).
Időkeret: Month 6
|
Single support time will be measured with the GAITRite® Electronic Walkway. |
Month 6
|
|
Single support time left and right foot (s).
Időkeret: Year 1
|
Single support time will be measured with the GAITRite® Electronic Walkway. |
Year 1
|
|
Single support time left and right foot (s).
Időkeret: Year 2
|
Single support time will be measured with the GAITRite® Electronic Walkway. |
Year 2
|
|
Single support time left and right foot (s).
Időkeret: Year 5
|
Single support time will be measured with the GAITRite® Electronic Walkway. |
Year 5
|
|
Double support time (s).
Időkeret: Day 0
|
: Double support time will be measured with the GAITRite® Electronic Walkway. |
Day 0
|
|
Double support time (s).
Időkeret: Month 6
|
: Double support time will be measured with the GAITRite® Electronic Walkway. |
Month 6
|
|
Double support time (s).
Időkeret: YEar 1
|
: Double support time will be measured with the GAITRite® Electronic Walkway. |
YEar 1
|
|
Double support time (s).
Időkeret: Year 2
|
: Double support time will be measured with the GAITRite® Electronic Walkway. |
Year 2
|
|
Double support time (s).
Időkeret: Year 5
|
: Double support time will be measured with the GAITRite® Electronic Walkway. |
Year 5
|
|
Swing time (s).
Időkeret: Day 0
|
: Swing time will be measured with the GAITRite® Electronic Walkway. |
Day 0
|
|
Swing time (s).
Időkeret: Month 6
|
: Swing time will be measured with the GAITRite® Electronic Walkway. |
Month 6
|
|
Swing time (s).
Időkeret: Year 1
|
: Swing time will be measured with the GAITRite® Electronic Walkway. |
Year 1
|
|
Swing time (s).
Időkeret: Year 2
|
: Swing time will be measured with the GAITRite® Electronic Walkway. |
Year 2
|
|
Swing time (s).
Időkeret: Year 5
|
: Swing time will be measured with the GAITRite® Electronic Walkway. |
Year 5
|
|
Swing phase (as a % of walking cycle).
Időkeret: DAy 0
|
: Swing phase will be measured with the GAITRite® Electronic Walkway. |
DAy 0
|
|
Swing phase (as a % of walking cycle).
Időkeret: Month 6
|
: Swing phase will be measured with the GAITRite® Electronic Walkway. |
Month 6
|
|
Swing phase (as a % of walking cycle).
Időkeret: Year 1
|
: Swing phase will be measured with the GAITRite® Electronic Walkway. |
Year 1
|
|
Swing phase (as a % of walking cycle).
Időkeret: Year 2
|
: Swing phase will be measured with the GAITRite® Electronic Walkway. |
Year 2
|
|
Swing phase (as a % of walking cycle).
Időkeret: Year 5
|
: Swing phase will be measured with the GAITRite® Electronic Walkway. |
Year 5
|
|
Stance phase (as a % of walking cycle).
Időkeret: Day 0
|
Stance phase will be measured with the GAITRite® Electronic Walkway. |
Day 0
|
|
Stance phase (as a % of walking cycle).
Időkeret: Month 6
|
Stance phase will be measured with the GAITRite® Electronic Walkway. |
Month 6
|
|
Stance phase (as a % of walking cycle).
Időkeret: Year 1
|
Stance phase will be measured with the GAITRite® Electronic Walkway. |
Year 1
|
|
Stance phase (as a % of walking cycle).
Időkeret: Year 2
|
Stance phase will be measured with the GAITRite® Electronic Walkway. |
Year 2
|
|
Stance phase (as a % of walking cycle).
Időkeret: Year 5
|
Stance phase will be measured with the GAITRite® Electronic Walkway. |
Year 5
|
|
Vo2max (maximal oxygen consumption) (mL/Kg/min).
Időkeret: Day 0
|
: Vo2max will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer. |
Day 0
|
|
Vo2max (maximal oxygen consumption) (mL/Kg/min).
Időkeret: Month 6
|
: Vo2max will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer. |
Month 6
|
|
Vo2max (maximal oxygen consumption) (mL/Kg/min).
Időkeret: Year 1
|
: Vo2max will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer. |
Year 1
|
|
Vo2max (maximal oxygen consumption) (mL/Kg/min).
Időkeret: Year 2
|
: Vo2max will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer. |
Year 2
|
|
Vo2max (maximal oxygen consumption) (mL/Kg/min).
Időkeret: Year 5
|
: Vo2max will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer. |
Year 5
|
|
Maximum heart rate (bpm).
Időkeret: Day 0
|
Maximum heart rate will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer. |
Day 0
|
|
Maximum heart rate (bpm).
Időkeret: Month 6
|
Maximum heart rate will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer. |
Month 6
|
|
Maximum heart rate (bpm).
Időkeret: Year 1
|
Maximum heart rate will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer. |
Year 1
|
|
Maximum heart rate (bpm).
Időkeret: Year 2
|
Maximum heart rate will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer. |
Year 2
|
|
Maximum heart rate (bpm).
Időkeret: Year 5
|
Maximum heart rate will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer. |
Year 5
|
|
Maximum power (Watts).
Időkeret: Day 0
|
Maximum power will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer. |
Day 0
|
|
Maximum power (Watts).
Időkeret: Month 6
|
Maximum power will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer. |
Month 6
|
|
Maximum power (Watts).
Időkeret: Year 1
|
Maximum power will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer. |
Year 1
|
|
Maximum power (Watts).
Időkeret: Year 2
|
Maximum power will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer. |
Year 2
|
|
Maximum power (Watts).
Időkeret: Year 5
|
Maximum power will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer. |
Year 5
|
|
Threshold power (Watts).
Időkeret: Day 0
|
Threshold power will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer. |
Day 0
|
|
Threshold power (Watts).
Időkeret: Month 6
|
Threshold power will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer. |
Month 6
|
|
Threshold power (Watts).
Időkeret: Year 1
|
Threshold power will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer. |
Year 1
|
|
Threshold power (Watts).
Időkeret: Year 2
|
Threshold power will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer. |
Year 2
|
|
Threshold power (Watts).
Időkeret: Year 5
|
Threshold power will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer. |
Year 5
|
|
Threshold heart rate (bpm).
Időkeret: DAy 0
|
Threshold heart will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer. |
DAy 0
|
|
Threshold heart rate (bpm).
Időkeret: Month 6
|
Threshold heart will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer. |
Month 6
|
|
Threshold heart rate (bpm).
Időkeret: Year 1
|
Threshold heart will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer. |
Year 1
|
|
Threshold heart rate (bpm).
Időkeret: Year 2
|
Threshold heart will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer. |
Year 2
|
|
Threshold heart rate (bpm).
Időkeret: Year 5
|
Threshold heart will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer. |
Year 5
|
|
Forced vital Capacity (L).
Időkeret: Day 0
|
: Forced vital Capacity will be measured with a spirometry test. |
Day 0
|
|
Forced vital Capacity (L).
Időkeret: Month 6
|
: Forced vital Capacity will be measured with a spirometry test. |
Month 6
|
|
Forced vital Capacity (L).
Időkeret: Year 1
|
: Forced vital Capacity will be measured with a spirometry test. |
Year 1
|
|
Forced vital Capacity (L).
Időkeret: Year 2
|
: Forced vital Capacity will be measured with a spirometry test. |
Year 2
|
|
Forced vital Capacity (L).
Időkeret: Year 5
|
: Forced vital Capacity will be measured with a spirometry test. |
Year 5
|
|
Forced Expiratory volume (L)
Időkeret: Day 0
|
Forced Expiratory volume will be measured with a spirometry test. |
Day 0
|
|
Forced Expiratory volume (L)
Időkeret: Month 6
|
Forced Expiratory volume will be measured with a spirometry test. |
Month 6
|
|
Forced Expiratory volume (L)
Időkeret: Year 1
|
Forced Expiratory volume will be measured with a spirometry test. |
Year 1
|
|
Forced Expiratory volume (L)
Időkeret: Year 2
|
Forced Expiratory volume will be measured with a spirometry test. |
Year 2
|
|
Forced Expiratory volume (L)
Időkeret: Year 5
|
Forced Expiratory volume will be measured with a spirometry test. |
Year 5
|
|
Tiffeneau ratio (%).
Időkeret: Day 0
|
Tiffeneau ratio will be calculated by dividing the Forced Expiratory volume to the Forced vital Capacity. |
Day 0
|
|
Tiffeneau ratio (%).
Időkeret: Month 6
|
Tiffeneau ratio will be calculated by dividing the Forced Expiratory volume to the Forced vital Capacity. |
Month 6
|
|
Tiffeneau ratio (%).
Időkeret: Year 1
|
Tiffeneau ratio will be calculated by dividing the Forced Expiratory volume to the Forced vital Capacity. |
Year 1
|
|
Tiffeneau ratio (%).
Időkeret: Year 2
|
Tiffeneau ratio will be calculated by dividing the Forced Expiratory volume to the Forced vital Capacity. |
Year 2
|
|
Tiffeneau ratio (%).
Időkeret: Year 5
|
Tiffeneau ratio will be calculated by dividing the Forced Expiratory volume to the Forced vital Capacity. |
Year 5
|
|
Ventilatory reserve (%).
Időkeret: Day 0
|
Ventilatory reserve will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer. |
Day 0
|
|
Ventilatory reserve (%).
Időkeret: Month 6
|
Ventilatory reserve will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer. |
Month 6
|
|
Ventilatory reserve (%).
Időkeret: Year 1
|
Ventilatory reserve will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer. |
Year 1
|
|
Ventilatory reserve (%).
Időkeret: Year 2
|
Ventilatory reserve will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer. |
Year 2
|
|
Ventilatory reserve (%).
Időkeret: Year 5
|
Ventilatory reserve will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer. |
Year 5
|
|
Physical activity
Időkeret: Day 0
|
Physical activity will be measured using the Global Physical Activity Questionnaire (GPAQ) |
Day 0
|
|
Physical activity
Időkeret: Month 6
|
Physical activity will be measured using the Global Physical Activity Questionnaire (GPAQ) |
Month 6
|
|
Physical activity
Időkeret: Year 1
|
Physical activity will be measured using the Global Physical Activity Questionnaire (GPAQ) |
Year 1
|
|
Physical activity
Időkeret: Year 2
|
Physical activity will be measured using the Global Physical Activity Questionnaire (GPAQ) |
Year 2
|
|
Physical activity
Időkeret: Year 5
|
Physical activity will be measured using the Global Physical Activity Questionnaire (GPAQ) |
Year 5
|
|
Functional capacity timed-up and go
Időkeret: Day 0
|
Functional capacity will be evaluated using the Timed-Up and Go test. |
Day 0
|
|
Functional capacity timed-up and go
Időkeret: Month 6
|
Functional capacity will be evaluated using the Timed-Up and Go test. |
Month 6
|
|
Functional capacity timed-up and go
Időkeret: Year 1
|
Functional capacity will be evaluated using the Timed-Up and Go test. |
Year 1
|
|
Functional capacity timed-up and go
Időkeret: Year 2
|
Functional capacity will be evaluated using the Timed-Up and Go test. |
Year 2
|
|
Functional capacity timed-up and go
Időkeret: Year 5
|
Functional capacity will be evaluated using the Timed-Up and Go test. |
Year 5
|
|
Functional capacity TDM6
Időkeret: Day 0
|
Functional capacity will be evaluated using the 6-minute walk test. |
Day 0
|
|
Functional capacity TDM6
Időkeret: Month 6
|
Functional capacity will be evaluated using the 6-minute walk test. |
Month 6
|
|
Functional capacity TDM6
Időkeret: Year 1
|
Functional capacity will be evaluated using the 6-minute walk test. |
Year 1
|
|
Functional capacity TDM6
Időkeret: Year 2
|
Functional capacity will be evaluated using the 6-minute walk test. |
Year 2
|
|
Functional capacity TDM6
Időkeret: Year 5
|
Functional capacity will be evaluated using the 6-minute walk test. |
Year 5
|
|
Functional capacity Five Times Sit to Stand test.
Időkeret: Day 0
|
Functional capacity will be evaluated using the Five Times Sit to Stand test. |
Day 0
|
|
Functional capacity Five Times Sit to Stand test.
Időkeret: Month 6
|
Functional capacity will be evaluated using the Five Times Sit to Stand test. |
Month 6
|
|
Functional capacity Five Times Sit to Stand test.
Időkeret: Year 1
|
Functional capacity will be evaluated using the Five Times Sit to Stand test. |
Year 1
|
|
Functional capacity Five Times Sit to Stand test.
Időkeret: Year 2
|
Functional capacity will be evaluated using the Five Times Sit to Stand test. |
Year 2
|
|
Functional capacity Five Times Sit to Stand test.
Időkeret: Year 5
|
Functional capacity will be evaluated using the Five Times Sit to Stand test. |
Year 5
|
|
Functional capacity SPPB
Időkeret: Day 0
|
Functional capacity will be evaluated using the Five Times Sit to Stand test.Functional capacity will be evaluated using the Short Physical Performance Battery test. |
Day 0
|
|
Functional capacity SPPB
Időkeret: Month 6
|
Functional capacity will be evaluated using the Five Times Sit to Stand test.Functional capacity will be evaluated using the Short Physical Performance Battery test. |
Month 6
|
|
Functional capacity SPPB
Időkeret: Year 1
|
Functional capacity will be evaluated using the Five Times Sit to Stand test.Functional capacity will be evaluated using the Short Physical Performance Battery test. |
Year 1
|
|
Functional capacity SPPB
Időkeret: Year 2
|
Functional capacity will be evaluated using the Five Times Sit to Stand test.Functional capacity will be evaluated using the Short Physical Performance Battery test. |
Year 2
|
|
Functional capacity SPPB
Időkeret: Year 5
|
Functional capacity will be evaluated using the Five Times Sit to Stand test.Functional capacity will be evaluated using the Short Physical Performance Battery test. |
Year 5
|
|
Functional capacity the mini-BESTest.
Időkeret: Day 0
|
Functional capacity will be evaluated using the mini-BESTest. |
Day 0
|
|
Functional capacity the mini-BESTest.
Időkeret: Month 6
|
Functional capacity will be evaluated using the mini-BESTest. |
Month 6
|
|
Functional capacity the mini-BESTest.
Időkeret: Year 1
|
Functional capacity will be evaluated using the mini-BESTest. |
Year 1
|
|
Functional capacity the mini-BESTest.
Időkeret: Year 2
|
Functional capacity will be evaluated using the mini-BESTest. |
Year 2
|
|
Functional capacity the mini-BESTest.
Időkeret: Year 5
|
Functional capacity will be evaluated using the mini-BESTest. |
Year 5
|
|
Functional capacity Berg Balance Scale.
Időkeret: Day 0
|
Functional capacity will be evaluated using the Berg Balance Scale. |
Day 0
|
|
Functional capacity Berg Balance Scale.
Időkeret: Month 6
|
Functional capacity will be evaluated using the Berg Balance Scale. |
Month 6
|
|
Functional capacity Berg Balance Scale.
Időkeret: Year 1
|
Functional capacity will be evaluated using the Berg Balance Scale. |
Year 1
|
|
Functional capacity Berg Balance Scale.
Időkeret: Year 2
|
Functional capacity will be evaluated using the Berg Balance Scale. |
Year 2
|
|
Functional capacity Berg Balance Scale.
Időkeret: Year 5
|
Functional capacity will be evaluated using the Berg Balance Scale. |
Year 5
|
|
Functional capacity 10-meter walk test
Időkeret: Day 0
|
Functional capacity will be evaluated using the 10-meter walk test (at usual and maximal pace). |
Day 0
|
|
Functional capacity 10-meter walk test
Időkeret: Month 6
|
Functional capacity will be evaluated using the 10-meter walk test (at usual and maximal pace). |
Month 6
|
|
Functional capacity 10-meter walk test
Időkeret: Year 1
|
Functional capacity will be evaluated using the 10-meter walk test (at usual and maximal pace). |
Year 1
|
|
Functional capacity 10-meter walk test
Időkeret: Year 2
|
Functional capacity will be evaluated using the 10-meter walk test (at usual and maximal pace). |
Year 2
|
|
Functional capacity 10-meter walk test
Időkeret: Year 5
|
Functional capacity will be evaluated using the 10-meter walk test (at usual and maximal pace). |
Year 5
|
|
Dyspnea
Időkeret: Day 0
|
Dyspnea will be evaluated by a Numeric Rating scale ranging from 0 to 10. |
Day 0
|
|
Dyspnea
Időkeret: Month 6
|
Dyspnea will be evaluated by a Numeric Rating scale ranging from 0 to 10. |
Month 6
|
|
Dyspnea
Időkeret: Year 1
|
Dyspnea will be evaluated by a Numeric Rating scale ranging from 0 to 10. |
Year 1
|
|
Dyspnea
Időkeret: Year 2
|
Dyspnea will be evaluated by a Numeric Rating scale ranging from 0 to 10. |
Year 2
|
|
Dyspnea
Időkeret: Year 5
|
Dyspnea will be evaluated by a Numeric Rating scale ranging from 0 to 10. |
Year 5
|
|
Perceived exertion before, during and after effort
Időkeret: DAy 0
|
Perceived exertion will be evaluated by a Numeric Rating scale ranging from 0 to 10. |
DAy 0
|
|
Perceived exertion before, during and after effort
Időkeret: Month 6
|
Perceived exertion will be evaluated by a Numeric Rating scale ranging from 0 to 10. |
Month 6
|
|
Perceived exertion before, during and after effort
Időkeret: Year 1
|
Perceived exertion will be evaluated by a Numeric Rating scale ranging from 0 to 10. |
Year 1
|
|
Perceived exertion before, during and after effort
Időkeret: Year 2
|
Perceived exertion will be evaluated by a Numeric Rating scale ranging from 0 to 10. |
Year 2
|
|
Perceived exertion before, during and after effort
Időkeret: Year 5
|
Perceived exertion will be evaluated by a Numeric Rating scale ranging from 0 to 10. |
Year 5
|
|
Musculoskeletal Pain
Időkeret: Day 0
|
: Pain will be measured by a visual analogue scale (VAS) ranging from 0 to 10 and possibly as appropriate by other questionnaires or specific scales. |
Day 0
|
|
Musculoskeletal Pain
Időkeret: Month 6
|
: Pain will be measured by a visual analogue scale (VAS) ranging from 0 to 10 and possibly as appropriate by other questionnaires or specific scales. |
Month 6
|
|
Musculoskeletal Pain
Időkeret: Year 1
|
: Pain will be measured by a visual analogue scale (VAS) ranging from 0 to 10 and possibly as appropriate by other questionnaires or specific scales. |
Year 1
|
|
Musculoskeletal Pain
Időkeret: Year 2
|
: Pain will be measured by a visual analogue scale (VAS) ranging from 0 to 10 and possibly as appropriate by other questionnaires or specific scales. |
Year 2
|
|
Musculoskeletal Pain
Időkeret: Year 5
|
: Pain will be measured by a visual analogue scale (VAS) ranging from 0 to 10 and possibly as appropriate by other questionnaires or specific scales. |
Year 5
|
|
Sarcopenia risk
Időkeret: Day 0
|
Sarcopenia risk will be evaluated with the SARC-F Questionnaire. |
Day 0
|
|
Sarcopenia risk
Időkeret: Month 6
|
Sarcopenia risk will be evaluated with the SARC-F Questionnaire. |
Month 6
|
|
Sarcopenia risk
Időkeret: Year 1
|
Sarcopenia risk will be evaluated with the SARC-F Questionnaire. |
Year 1
|
|
Sarcopenia risk
Időkeret: Year 2
|
Sarcopenia risk will be evaluated with the SARC-F Questionnaire. |
Year 2
|
|
Sarcopenia risk
Időkeret: Year 5
|
Sarcopenia risk will be evaluated with the SARC-F Questionnaire. |
Year 5
|
|
Social insecurity
Időkeret: Day 0
|
Social insecurity will be evaluated with the EPICES Score Questionnaire. |
Day 0
|
|
Social insecurity
Időkeret: Month 6
|
Social insecurity will be evaluated with the EPICES Score Questionnaire. |
Month 6
|
|
Social insecurity
Időkeret: Year 1
|
Social insecurity will be evaluated with the EPICES Score Questionnaire. |
Year 1
|
|
Social insecurity
Időkeret: Year 2
|
Social insecurity will be evaluated with the EPICES Score Questionnaire. |
Year 2
|
|
Social insecurity
Időkeret: Year 5
|
Social insecurity will be evaluated with the EPICES Score Questionnaire. |
Year 5
|
|
Kinesiophobia
Időkeret: Day 0
|
Kinesiophobia will be evaluated with the TAMPA Scale. |
Day 0
|
|
Kinesiophobia
Időkeret: Month 6
|
Kinesiophobia will be evaluated with the TAMPA Scale. |
Month 6
|
|
Kinesiophobia
Időkeret: Year 1
|
Kinesiophobia will be evaluated with the TAMPA Scale. |
Year 1
|
|
Kinesiophobia
Időkeret: Year 2
|
Kinesiophobia will be evaluated with the TAMPA Scale. |
Year 2
|
|
Kinesiophobia
Időkeret: Year 5
|
Kinesiophobia will be evaluated with the TAMPA Scale. |
Year 5
|
|
Quality of life
Időkeret: Day 0
|
Quality of life will be evaluated with the 36-Item Short Form Survey. |
Day 0
|
|
Quality of life
Időkeret: Month 6
|
Quality of life will be evaluated with the 36-Item Short Form Survey. |
Month 6
|
|
Quality of life
Időkeret: Year 1
|
Quality of life will be evaluated with the 36-Item Short Form Survey. |
Year 1
|
|
Quality of life
Időkeret: Year 2
|
Quality of life will be evaluated with the 36-Item Short Form Survey. |
Year 2
|
|
Quality of life
Időkeret: Year 5
|
Quality of life will be evaluated with the 36-Item Short Form Survey. |
Year 5
|
|
: Balance confidence in performing various activities
Időkeret: Day 0
|
Self-report balance confidence will be evaluated with the Activities-specific Balance Confidence (ABC) Scale.vey. |
Day 0
|
|
: Balance confidence in performing various activities
Időkeret: Month 6
|
Self-report balance confidence will be evaluated with the Activities-specific Balance Confidence (ABC) Scale.vey. |
Month 6
|
|
: Balance confidence in performing various activities
Időkeret: Year 1
|
Self-report balance confidence will be evaluated with the Activities-specific Balance Confidence (ABC) Scale.vey. |
Year 1
|
|
: Balance confidence in performing various activities
Időkeret: Year 2
|
Self-report balance confidence will be evaluated with the Activities-specific Balance Confidence (ABC) Scale.vey. |
Year 2
|
|
: Balance confidence in performing various activities
Időkeret: Year 5
|
Self-report balance confidence will be evaluated with the Activities-specific Balance Confidence (ABC) Scale.vey. |
Year 5
|
|
Functioning in regards to activities of daily living.
Időkeret: Day 0
|
Functioning will be evaluated with the Lawton Instrumental Activities of Daily Living (IADL) Scale. |
Day 0
|
|
Functioning in regards to activities of daily living.
Időkeret: Month 6
|
Functioning will be evaluated with the Lawton Instrumental Activities of Daily Living (IADL) Scale. |
Month 6
|
|
Functioning in regards to activities of daily living.
Időkeret: Year 1
|
Functioning will be evaluated with the Lawton Instrumental Activities of Daily Living (IADL) Scale. |
Year 1
|
|
Functioning in regards to activities of daily living.
Időkeret: Year 2
|
Functioning will be evaluated with the Lawton Instrumental Activities of Daily Living (IADL) Scale. |
Year 2
|
|
Functioning in regards to activities of daily living.
Időkeret: Year 5
|
Functioning will be evaluated with the Lawton Instrumental Activities of Daily Living (IADL) Scale. |
Year 5
|
|
Exhaustion
Időkeret: Day 0
|
Exhaustion will be evaluated with the FACIT-F Questionnaire. |
Day 0
|
|
Exhaustion
Időkeret: Month 6
|
Exhaustion will be evaluated with the FACIT-F Questionnaire. |
Month 6
|
|
Exhaustion
Időkeret: Year 1
|
Exhaustion will be evaluated with the FACIT-F Questionnaire. |
Year 1
|
|
Exhaustion
Időkeret: Year 2
|
Exhaustion will be evaluated with the FACIT-F Questionnaire. |
Year 2
|
|
Exhaustion
Időkeret: Year 5
|
Exhaustion will be evaluated with the FACIT-F Questionnaire. |
Year 5
|
|
Patient's opinion about their knee and associated problems
Időkeret: Day 0
|
: Outcomes will be evaluated with the Knee Injury and Osteoarthritis Outcome Score (KOOS). |
Day 0
|
|
Patient's opinion about their knee and associated problems
Időkeret: Month 6
|
: Outcomes will be evaluated with the Knee Injury and Osteoarthritis Outcome Score (KOOS). |
Month 6
|
|
Patient's opinion about their knee and associated problems
Időkeret: Year 1
|
: Outcomes will be evaluated with the Knee Injury and Osteoarthritis Outcome Score (KOOS). |
Year 1
|
|
Patient's opinion about their knee and associated problems
Időkeret: Year 2
|
: Outcomes will be evaluated with the Knee Injury and Osteoarthritis Outcome Score (KOOS). |
Year 2
|
|
Patient's opinion about their knee and associated problems
Időkeret: Year 5
|
: Outcomes will be evaluated with the Knee Injury and Osteoarthritis Outcome Score (KOOS). |
Year 5
|
|
Patient's opinion about their hip and associated problems
Időkeret: Day 0
|
Outcomes will be evaluated with the Hip Injury and Osteoarthritis Outcome Score (HOOS). |
Day 0
|
|
Patient's opinion about their hip and associated problems
Időkeret: Month 6
|
Outcomes will be evaluated with the Hip Injury and Osteoarthritis Outcome Score (HOOS). |
Month 6
|
|
Patient's opinion about their hip and associated problems
Időkeret: Year 1
|
Outcomes will be evaluated with the Hip Injury and Osteoarthritis Outcome Score (HOOS). |
Year 1
|
|
Patient's opinion about their hip and associated problems
Időkeret: Year 2
|
Outcomes will be evaluated with the Hip Injury and Osteoarthritis Outcome Score (HOOS). |
Year 2
|
|
Patient's opinion about their hip and associated problems
Időkeret: Year 5
|
Outcomes will be evaluated with the Hip Injury and Osteoarthritis Outcome Score (HOOS). |
Year 5
|
|
Predicting discharge destination after total joint arthroplasty.
Időkeret: Day 0
|
: Discharge destination will be evaluated with the Risk Assessment and Prediction Tool (RAPT); |
Day 0
|
|
Predicting discharge destination after total joint arthroplasty.
Időkeret: Month 6
|
: Discharge destination will be evaluated with the Risk Assessment and Prediction Tool (RAPT); |
Month 6
|
|
Physical function in myositis patients
Időkeret: Day 0
|
Physical function will be evaluated with the Stanford Health Assessment Questionnaire. |
Day 0
|
|
Physical function in myositis patients
Időkeret: Month 6
|
Physical function will be evaluated with the Stanford Health Assessment Questionnaire. |
Month 6
|
|
Physical function in myositis patients
Időkeret: Year 1
|
Physical function will be evaluated with the Stanford Health Assessment Questionnaire. |
Year 1
|
|
Physical function in myositis patients
Időkeret: Year 2
|
Physical function will be evaluated with the Stanford Health Assessment Questionnaire. |
Year 2
|
|
Physical function in myositis patients
Időkeret: Year 5
|
Physical function will be evaluated with the Stanford Health Assessment Questionnaire. |
Year 5
|
|
Quality of life in Parkinson's Disease
Időkeret: Day 0
|
Quality of life will be measured with the Parkinson's Disease Questionnaire-39 (PDQ-39). |
Day 0
|
|
Quality of life in Parkinson's Disease
Időkeret: Month 6
|
Quality of life will be measured with the Parkinson's Disease Questionnaire-39 (PDQ-39). |
Month 6
|
|
Quality of life in Parkinson's Disease
Időkeret: Year 1
|
Quality of life will be measured with the Parkinson's Disease Questionnaire-39 (PDQ-39). |
Year 1
|
|
Quality of life in Parkinson's Disease
Időkeret: Year 2
|
Quality of life will be measured with the Parkinson's Disease Questionnaire-39 (PDQ-39). |
Year 2
|
|
Quality of life in Parkinson's Disease
Időkeret: Year 5
|
Quality of life will be measured with the Parkinson's Disease Questionnaire-39 (PDQ-39). |
Year 5
|
|
Actimetry.
Időkeret: during 5 consecutive days after day 0
|
Actimetry data (energy expenditure, number of steps, sedentary time, total physical activity, etc.) will be obtained with the WGT3X-BT Actigraph inertial sensor unit. |
during 5 consecutive days after day 0
|
|
Title: Muscle Cross-Sectional Area (CSA) of the quadriceps muscles (cm^2)
Időkeret: Day 0
|
Cross-sectional area of the quadriceps muscles will be measured by conventional B-mode ultrasound using the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Day 0
|
|
Title: Muscle Cross-Sectional Area (CSA) of the quadriceps muscles (cm^2)
Időkeret: Month 6
|
Cross-sectional area of the quadriceps muscles will be measured by conventional B-mode ultrasound using the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Month 6
|
|
Title: Muscle Cross-Sectional Area (CSA) of the quadriceps muscles (cm^2)
Időkeret: Year 1
|
Cross-sectional area of the quadriceps muscles will be measured by conventional B-mode ultrasound using the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Year 1
|
|
Title: Muscle Cross-Sectional Area (CSA) of the quadriceps muscles (cm^2)
Időkeret: Year 2
|
Cross-sectional area of the quadriceps muscles will be measured by conventional B-mode ultrasound using the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Year 2
|
|
Title: Muscle Cross-Sectional Area (CSA) of the quadriceps muscles (cm^2)
Időkeret: Year 5
|
Cross-sectional area of the quadriceps muscles will be measured by conventional B-mode ultrasound using the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Year 5
|
|
Subcutaneous Adipose Tissue Thickness Over the Quadriceps (mm)
Időkeret: Day 0
|
Thickness of the subcutaneous adipose tissue overlying the quadriceps muscles will be measured by conventional B-mode ultrasound using the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Day 0
|
|
Subcutaneous Adipose Tissue Thickness Over the Quadriceps (mm)
Időkeret: Month 6
|
Thickness of the subcutaneous adipose tissue overlying the quadriceps muscles will be measured by conventional B-mode ultrasound using the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Month 6
|
|
Subcutaneous Adipose Tissue Thickness Over the Quadriceps (mm)
Időkeret: Year 1
|
Thickness of the subcutaneous adipose tissue overlying the quadriceps muscles will be measured by conventional B-mode ultrasound using the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Year 1
|
|
Subcutaneous Adipose Tissue Thickness Over the Quadriceps (mm)
Időkeret: Year 2
|
Thickness of the subcutaneous adipose tissue overlying the quadriceps muscles will be measured by conventional B-mode ultrasound using the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Year 2
|
|
Subcutaneous Adipose Tissue Thickness Over the Quadriceps (mm)
Időkeret: Year 5
|
Thickness of the subcutaneous adipose tissue overlying the quadriceps muscles will be measured by conventional B-mode ultrasound using the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Year 5
|
|
Muscle Cross-Sectional Area (CSA) of the Medial Gastrocnemius (cm^2)
Időkeret: Day 0
|
Cross-sectional area of the medial gastrocnemius muscle will be measured by conventional B-mode ultrasound using the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Day 0
|
|
Muscle Cross-Sectional Area (CSA) of the Medial Gastrocnemius (cm^2)
Időkeret: Month 6
|
Cross-sectional area of the medial gastrocnemius muscle will be measured by conventional B-mode ultrasound using the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Month 6
|
|
Muscle Cross-Sectional Area (CSA) of the Medial Gastrocnemius (cm^2)
Időkeret: Year 1
|
Cross-sectional area of the medial gastrocnemius muscle will be measured by conventional B-mode ultrasound using the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Year 1
|
|
Muscle Cross-Sectional Area (CSA) of the Medial Gastrocnemius (cm^2)
Időkeret: Year 2
|
Cross-sectional area of the medial gastrocnemius muscle will be measured by conventional B-mode ultrasound using the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Year 2
|
|
Muscle Cross-Sectional Area (CSA) of the Medial Gastrocnemius (cm^2)
Időkeret: Year 5
|
Cross-sectional area of the medial gastrocnemius muscle will be measured by conventional B-mode ultrasound using the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Year 5
|
|
Muscle Cross-Sectional Area (CSA) of the Lateral Gastrocnemius (cm^2)
Időkeret: Day 0
|
Cross-sectional area of the lateral gastrocnemius muscle will be measured by conventional B-mode ultrasound using the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Day 0
|
|
Muscle Cross-Sectional Area (CSA) of the Lateral Gastrocnemius (cm^2)
Időkeret: Month 6
|
Cross-sectional area of the lateral gastrocnemius muscle will be measured by conventional B-mode ultrasound using the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Month 6
|
|
Muscle Cross-Sectional Area (CSA) of the Lateral Gastrocnemius (cm^2)
Időkeret: Year 1
|
Cross-sectional area of the lateral gastrocnemius muscle will be measured by conventional B-mode ultrasound using the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Year 1
|
|
Muscle Cross-Sectional Area (CSA) of the Lateral Gastrocnemius (cm^2)
Időkeret: Year 2
|
Cross-sectional area of the lateral gastrocnemius muscle will be measured by conventional B-mode ultrasound using the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Year 2
|
|
Muscle Cross-Sectional Area (CSA) of the Lateral Gastrocnemius (cm^2)
Időkeret: Year 5
|
Cross-sectional area of the lateral gastrocnemius muscle will be measured by conventional B-mode ultrasound using the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Year 5
|
|
Quadriceps muscles Quality Assessed by Shear Wave Elastography (kPa or m/s)
Időkeret: Day 0
|
Muscle stiffness, reflecting muscle quality, will be assessed by Shear Wave Elastography (SWE) using the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Day 0
|
|
Quadriceps muscles Quality Assessed by Shear Wave Elastography (kPa or m/s)
Időkeret: Month 6
|
Muscle stiffness, reflecting muscle quality, will be assessed by Shear Wave Elastography (SWE) using the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Month 6
|
|
Quadriceps muscles Quality Assessed by Shear Wave Elastography (kPa or m/s)
Időkeret: Year 1
|
Muscle stiffness, reflecting muscle quality, will be assessed by Shear Wave Elastography (SWE) using the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Year 1
|
|
Quadriceps muscles Quality Assessed by Shear Wave Elastography (kPa or m/s)
Időkeret: Year 2
|
Muscle stiffness, reflecting muscle quality, will be assessed by Shear Wave Elastography (SWE) using the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Year 2
|
|
Quadriceps muscles Quality Assessed by Shear Wave Elastography (kPa or m/s)
Időkeret: Year 5
|
Muscle stiffness, reflecting muscle quality, will be assessed by Shear Wave Elastography (SWE) using the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Year 5
|
|
Medial Gastrocnemius Quality Assessed by Shear Wave Elastography (kPa or m/s)
Időkeret: Day 0
|
Muscle stiffness, reflecting muscle quality, will be assessed by Shear Wave Elastography (SWE) using the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Day 0
|
|
Medial Gastrocnemius Quality Assessed by Shear Wave Elastography (kPa or m/s)
Időkeret: Month 6
|
Muscle stiffness, reflecting muscle quality, will be assessed by Shear Wave Elastography (SWE) using the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Month 6
|
|
Medial Gastrocnemius Quality Assessed by Shear Wave Elastography (kPa or m/s)
Időkeret: Year 1
|
Muscle stiffness, reflecting muscle quality, will be assessed by Shear Wave Elastography (SWE) using the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Year 1
|
|
Medial Gastrocnemius Quality Assessed by Shear Wave Elastography (kPa or m/s)
Időkeret: Year 2
|
Muscle stiffness, reflecting muscle quality, will be assessed by Shear Wave Elastography (SWE) using the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Year 2
|
|
Medial Gastrocnemius Quality Assessed by Shear Wave Elastography (kPa or m/s)
Időkeret: Year 5
|
Muscle stiffness, reflecting muscle quality, will be assessed by Shear Wave Elastography (SWE) using the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Year 5
|
|
Lateral Gastrocnemius Quality Assessed by Shear Wave Elastography (kPa or m/s)
Időkeret: Day 0
|
Muscle stiffness, reflecting muscle quality, will be assessed by Shear Wave Elastography (SWE) using the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Day 0
|
|
Lateral Gastrocnemius Quality Assessed by Shear Wave Elastography (kPa or m/s)
Időkeret: Month 6
|
Muscle stiffness, reflecting muscle quality, will be assessed by Shear Wave Elastography (SWE) using the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Month 6
|
|
Lateral Gastrocnemius Quality Assessed by Shear Wave Elastography (kPa or m/s)
Időkeret: Year 1
|
Muscle stiffness, reflecting muscle quality, will be assessed by Shear Wave Elastography (SWE) using the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Year 1
|
|
Lateral Gastrocnemius Quality Assessed by Shear Wave Elastography (kPa or m/s)
Időkeret: Year 2
|
Muscle stiffness, reflecting muscle quality, will be assessed by Shear Wave Elastography (SWE) using the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Year 2
|
|
Lateral Gastrocnemius Quality Assessed by Shear Wave Elastography (kPa or m/s)
Időkeret: Year 5
|
Muscle stiffness, reflecting muscle quality, will be assessed by Shear Wave Elastography (SWE) using the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Year 5
|
|
Quadriceps muscles Microvascularization Assessed by Superb Microvascular Imaging (SMI) (%)
Időkeret: Day 0
|
Muscle microvascularization will be assessed using Superb Microvascular Imaging (SMI), a Doppler-based technique that detects very low-velocity blood flow without contrast agent injection, using the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Day 0
|
|
Quadriceps muscles Microvascularization Assessed by Superb Microvascular Imaging (SMI) (%)
Időkeret: Month 6
|
Muscle microvascularization will be assessed using Superb Microvascular Imaging (SMI), a Doppler-based technique that detects very low-velocity blood flow without contrast agent injection, using the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Month 6
|
|
Quadriceps muscles Microvascularization Assessed by Superb Microvascular Imaging (SMI) (%)
Időkeret: Year 1
|
Muscle microvascularization will be assessed using Superb Microvascular Imaging (SMI), a Doppler-based technique that detects very low-velocity blood flow without contrast agent injection, using the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Year 1
|
|
Quadriceps muscles Microvascularization Assessed by Superb Microvascular Imaging (SMI) (%)
Időkeret: Year 2
|
Muscle microvascularization will be assessed using Superb Microvascular Imaging (SMI), a Doppler-based technique that detects very low-velocity blood flow without contrast agent injection, using the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Year 2
|
|
Quadriceps muscles Microvascularization Assessed by Superb Microvascular Imaging (SMI) (%)
Időkeret: Year 5
|
Muscle microvascularization will be assessed using Superb Microvascular Imaging (SMI), a Doppler-based technique that detects very low-velocity blood flow without contrast agent injection, using the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Year 5
|
|
Medial Gastrocnemius Microvascularization Assessed by Superb Microvascular Imaging (SMI) (%)
Időkeret: Day 0
|
Muscle microvascularization will be assessed using Superb Microvascular Imaging (SMI), a Doppler-based technique that detects very low-velocity blood flow without contrast agent injection, using the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Day 0
|
|
Medial Gastrocnemius Microvascularization Assessed by Superb Microvascular Imaging (SMI) (%)
Időkeret: Month 6
|
Muscle microvascularization will be assessed using Superb Microvascular Imaging (SMI), a Doppler-based technique that detects very low-velocity blood flow without contrast agent injection, using the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Month 6
|
|
Medial Gastrocnemius Microvascularization Assessed by Superb Microvascular Imaging (SMI) (%)
Időkeret: Year 1
|
Muscle microvascularization will be assessed using Superb Microvascular Imaging (SMI), a Doppler-based technique that detects very low-velocity blood flow without contrast agent injection, using the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Year 1
|
|
Medial Gastrocnemius Microvascularization Assessed by Superb Microvascular Imaging (SMI) (%)
Időkeret: Year 2
|
Muscle microvascularization will be assessed using Superb Microvascular Imaging (SMI), a Doppler-based technique that detects very low-velocity blood flow without contrast agent injection, using the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Year 2
|
|
Medial Gastrocnemius Microvascularization Assessed by Superb Microvascular Imaging (SMI) (%)
Időkeret: Year 5
|
Muscle microvascularization will be assessed using Superb Microvascular Imaging (SMI), a Doppler-based technique that detects very low-velocity blood flow without contrast agent injection, using the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Year 5
|
|
Lateral Gastrocnemius Microvascularization Assessed by Superb Microvascular Imaging (SMI) (%)
Időkeret: Day 0
|
Muscle microvascularization will be assessed using Superb Microvascular Imaging (SMI), a Doppler-based technique that detects very low-velocity blood flow without contrast agent injection, using the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Day 0
|
|
Lateral Gastrocnemius Microvascularization Assessed by Superb Microvascular Imaging (SMI) (%)
Időkeret: Month 6
|
Muscle microvascularization will be assessed using Superb Microvascular Imaging (SMI), a Doppler-based technique that detects very low-velocity blood flow without contrast agent injection, using the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Month 6
|
|
Lateral Gastrocnemius Microvascularization Assessed by Superb Microvascular Imaging (SMI) (%)
Időkeret: Year 1
|
Muscle microvascularization will be assessed using Superb Microvascular Imaging (SMI), a Doppler-based technique that detects very low-velocity blood flow without contrast agent injection, using the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Year 1
|
|
Lateral Gastrocnemius Microvascularization Assessed by Superb Microvascular Imaging (SMI) (%)
Időkeret: Year 2
|
Muscle microvascularization will be assessed using Superb Microvascular Imaging (SMI), a Doppler-based technique that detects very low-velocity blood flow without contrast agent injection, using the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Year 2
|
|
Lateral Gastrocnemius Microvascularization Assessed by Superb Microvascular Imaging (SMI) (%)
Időkeret: Year 5
|
Muscle microvascularization will be assessed using Superb Microvascular Imaging (SMI), a Doppler-based technique that detects very low-velocity blood flow without contrast agent injection, using the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Year 5
|
|
Quadriceps muscles Blood Flow Velocity Measured by Doppler Ultrasound (cm/s)
Időkeret: Day 0
|
Muscle blood flow velocity will be measured using Doppler ultrasound with the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Day 0
|
|
Quadriceps muscles Blood Flow Velocity Measured by Doppler Ultrasound (cm/s)
Időkeret: Month 6
|
Muscle blood flow velocity will be measured using Doppler ultrasound with the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Month 6
|
|
Quadriceps muscles Blood Flow Velocity Measured by Doppler Ultrasound (cm/s)
Időkeret: Year 1
|
Muscle blood flow velocity will be measured using Doppler ultrasound with the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Year 1
|
|
Quadriceps muscles Blood Flow Velocity Measured by Doppler Ultrasound (cm/s)
Időkeret: Year 2
|
Muscle blood flow velocity will be measured using Doppler ultrasound with the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Year 2
|
|
Quadriceps muscles Blood Flow Velocity Measured by Doppler Ultrasound (cm/s)
Időkeret: Year 5
|
Muscle blood flow velocity will be measured using Doppler ultrasound with the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Year 5
|
|
Medial Gastrocnemius Blood Flow Velocity Measured by Doppler Ultrasound (cm/s)
Időkeret: Day 0
|
Muscle blood flow velocity will be measured using Doppler ultrasound with the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Day 0
|
|
Medial Gastrocnemius Blood Flow Velocity Measured by Doppler Ultrasound (cm/s)
Időkeret: Month 6
|
Muscle blood flow velocity will be measured using Doppler ultrasound with the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Month 6
|
|
Medial Gastrocnemius Blood Flow Velocity Measured by Doppler Ultrasound (cm/s)
Időkeret: Year 1
|
Muscle blood flow velocity will be measured using Doppler ultrasound with the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Year 1
|
|
Medial Gastrocnemius Blood Flow Velocity Measured by Doppler Ultrasound (cm/s)
Időkeret: Year 2
|
Muscle blood flow velocity will be measured using Doppler ultrasound with the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Year 2
|
|
Medial Gastrocnemius Blood Flow Velocity Measured by Doppler Ultrasound (cm/s)
Időkeret: Year 5
|
Muscle blood flow velocity will be measured using Doppler ultrasound with the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Year 5
|
|
Lateral Gastrocnemius Blood Flow Velocity Measured by Doppler Ultrasound (cm/s)
Időkeret: Day 0
|
Muscle blood flow velocity will be measured using Doppler ultrasound with the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Day 0
|
|
Lateral Gastrocnemius Blood Flow Velocity Measured by Doppler Ultrasound (cm/s)
Időkeret: Month 6
|
Muscle blood flow velocity will be measured using Doppler ultrasound with the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Month 6
|
|
Lateral Gastrocnemius Blood Flow Velocity Measured by Doppler Ultrasound (cm/s)
Időkeret: Year 1
|
Muscle blood flow velocity will be measured using Doppler ultrasound with the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Year 1
|
|
Lateral Gastrocnemius Blood Flow Velocity Measured by Doppler Ultrasound (cm/s)
Időkeret: Year 2
|
Muscle blood flow velocity will be measured using Doppler ultrasound with the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Year 2
|
|
Lateral Gastrocnemius Blood Flow Velocity Measured by Doppler Ultrasound (cm/s)
Időkeret: Year 5
|
Muscle blood flow velocity will be measured using Doppler ultrasound with the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Year 5
|
Együttműködők és nyomozók
Együttműködők
Nyomozók
- Kutatásvezető: Frédéric Costes, University Hospital, Clermont-Ferrand
Tanulmányi rekorddátumok
Tanulmány főbb dátumok
Tanulmány kezdete (Tényleges)
Elsődleges befejezés (Becsült)
A tanulmány befejezése (Becsült)
Tanulmányi regisztráció dátumai
Először benyújtva
Először nyújtották be, amely megfelel a minőségbiztosítási kritériumoknak
Első közzététel (Tényleges)
Tanulmányi rekordok frissítései
Utolsó frissítés közzétéve (Tényleges)
Az utolsó frissítés elküldve, amely megfelel a minőségbiztosítási kritériumoknak
Utolsó ellenőrzés
Több információ
A tanulmányhoz kapcsolódó kifejezések
Kulcsszavak
További vonatkozó MeSH feltételek
- Synucleinopathiák
- Agyi betegségek
- Központi idegrendszeri betegségek
- Idegrendszeri betegségek
- Patológiás folyamatok
- Táplálkozási zavarok
- Betegség tulajdonságai
- Túltáplálás
- Testsúly
- Légúti betegségek
- Tüdőbetegségek
- Tüdőbetegségek, obstruktív
- Neurodegeneratív betegségek
- Mozgási zavarok
- Túlsúly
- Parkinson-kór
- Basalis ganglion betegségek
- Kóros állapotok, jelek és tünetek
- Táplálkozási és anyagcsere-betegségek
- Jelek és tünetek
- Elhízottság
- Tüdőbetegség, krónikus obstruktív
- Parkinson kór
- Krónikus betegség
Egyéb vizsgálati azonosító számok
- RBHP 2019 COSTES
- 2019-A01017-50 (Egyéb azonosító: 2019-A01017-50)
Gyógyszer- és eszközinformációk, tanulmányi dokumentumok
Egy amerikai FDA által szabályozott gyógyszerkészítményt tanulmányoz
Egy amerikai FDA által szabályozott eszközterméket tanulmányoz
Ezt az információt közvetlenül a clinicaltrials.gov webhelyről szereztük be, változtatás nélkül. Ha bármilyen kérése van vizsgálati adatainak módosítására, eltávolítására vagy frissítésére, kérjük, írjon a következő címre: register@clinicaltrials.gov. Amint a változás bevezetésre kerül a clinicaltrials.gov oldalon, ez a webhelyünkön is automatikusan frissül. .